Hugo_Symbol	Variant_Classification	Protein_position	HGVSp_Short	Normal_Sample	IS-A-HOTSPOT	IS-A-3D-HOTSPOT	GENE_IN_ONCOKB	VARIANT_IN_ONCOKB	MUTATION_EFFECT	ONCOGENIC	LEVEL_1	LEVEL_2	LEVEL_3A	LEVEL_3B	LEVEL_4	LEVEL_R1	LEVEL_R2	LEVEL_R3	HIGHEST_LEVEL	CITATIONS	LEVEL_Dx1	LEVEL_Dx2	LEVEL_Dx3	HIGHEST_DX_LEVEL	LEVEL_Px1	LEVEL_Px2	LEVEL_Px3	HIGHEST_PX_LEVEL
ALK	Missense_Mutation	1275/1620	p.R1275Q	SAMPLE	Y		True	True	Gain-of-function	Oncogenic	Lorlatinib,Brigatinib								LEVEL_1	18923523;18923525;25517749;27049722;26829053;26554404;22072639;27432227;29074098;30413378;30892989;30280657;28475456								
ALOX12B	Missense_Mutation	527/701	p.V527M	SAMPLE			True	False	Unknown																			
ALOX12B	Missense_Mutation	521/701	p.Y521C	SAMPLE			True	False	Unknown																			
AMER1	Nonsense_Mutation	1049/1135	p.R1049*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26071483								
AMER1	Nonsense_Mutation	942/1135	p.R942*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26071483								
AMER1	Nonsense_Mutation	626/1135	p.R626*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26071483								
APC	Frame_Shift_Del	77-78/2843	p.D78Afs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Nonsense_Mutation	163/2843	p.Q163*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Nonsense_Mutation	283/2843	p.R283*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Frame_Shift_Del	398/2843	p.K398Efs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Nonsense_Mutation	405/2843	p.R405*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Frame_Shift_Del	491-494/2843	p.D491Efs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Nonsense_Mutation	991/2843	p.E991*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Nonsense_Mutation	1031/2843	p.Y1031*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Frame_Shift_Del	1060-1062/2843	p.Q1062*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Frame_Shift_Del	1270/2843	p.C1270Ffs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Frame_Shift_Del	1307-1309/2843	p.E1309Dfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Frame_Shift_Del	1462/2843	p.S1465Wfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Nonsense_Mutation	1545/2843	p.S1545*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Frame_Shift_Ins	1554/2843	p.T1556Nfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Frame_Shift_Del	2094/2843	p.P2094Rfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Nonsense_Mutation	2237/2843	p.R2237*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Frame_Shift_Del	2371-2372/2843	p.Q2372*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
APC	Frame_Shift_Ins	2380/2843	p.K2380Ifs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11062151;15561772;11257105								
ARID1A	Splice_Site	640/2285	p.X640_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					Tazemetostat,PLX2853				LEVEL_4	21900401;24899687;22009941;25625625;25686104;32506298;31913353;29760405								
ARID1B	Nonsense_Mutation	588/2249	p.E588*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28521285;23660946;26340334;22233809								
ARID1B	Splice_Site	1009/2249	p.X1009_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28521285;23660946;26340334;22233809								
ARID2	Nonsense_Mutation	35/1835	p.K35*	SAMPLE			True	False	Unknown																			
ARID2	Splice_Site	258/1835	p.X258_splice	SAMPLE			True	False	Unknown																			
ARID2	Frame_Shift_Del	1728-1731/1835	p.A1729Gfs*28	SAMPLE			True	False	Unknown																			
ARID5B	Frame_Shift_Del	935/1188	p.G936Afs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										Kawamata et al. Abstract# LB-150, AACR 2016(http://cancerres.aacrjournals.org/content/76/14_Supplement/LB-150)								
ASXL1	Frame_Shift_Del	34/1541	p.I34Tfs*39	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19388938;22897849;21455215;26095772;24216483		CMML,MDS	AMLMRC	LEVEL_Dx2	CMML,MDS,AML,PMF	PV		LEVEL_Px1
ASXL1	Splice_Site	158/1541	p.X158_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19388938;22897849;21455215;26095772;24216483		CMML,MDS	AMLMRC	LEVEL_Dx2	CMML,MDS,AML,PMF	PV		LEVEL_Px1
ASXL1	Frame_Shift_Ins	804-805/1541	p.T806Hfs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19388938;22897849;21455215;26095772;24216483		CMML,MDS	AMLMRC	LEVEL_Dx2	CMML,MDS,AML,PMF	PV		LEVEL_Px1
ASXL1	Nonsense_Mutation	925/1541	p.Q925*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19388938;22897849;21455215;26095772;24216483		CMML,MDS	AMLMRC	LEVEL_Dx2	CMML,MDS,AML,PMF	PV		LEVEL_Px1
ASXL2	Frame_Shift_Del	1070/1435	p.L1070Hfs*69	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24973361;Li et al. Abstract# 1509, ASH 2016(http://www.bloodjournal.org/content/128/22/1509)								
ASXL2	Frame_Shift_Del	513/1435	p.N513Kfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24973361;Li et al. Abstract# 1509, ASH 2016(http://www.bloodjournal.org/content/128/22/1509)								
ASXL2	Frame_Shift_Ins	52/1435	p.L53Sfs*15	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24973361;Li et al. Abstract# 1509, ASH 2016(http://www.bloodjournal.org/content/128/22/1509)								
ATM	Translation_Start_Site	1/3056	p.M1?	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	23/3056	p.R23*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	35/3056	p.R35Efs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	35/3056	p.R35*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	57/3056	p.W57*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	62/3056	p.X62_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	72-73/3056	p.E73Mfs*26	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	78/3056	p.K79Nfs*37	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	92/3056	p.K93Rfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	121/3056	p.L121*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	127/3056	p.V128*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	212/3056	p.S214Pfs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	248/3056	p.R248*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	250/3056	p.R250*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	253/3056	p.E253*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	293/3056	p.K293*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	299/3056	p.G301Vfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	301/3056	p.X301_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	342-343/3056	p.E343Ifs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	353/3056	p.C353Sfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	355/3056	p.X355_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Ins	380/3056	p.S381Rfs*27	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	416/3056	p.T417Pfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	428-429/3056	p.N429Vfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	445/3056	p.Q445*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	447/3056	p.R447*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	452/3056	p.T452Nfs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	457/3056	p.R457*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	468/3056	p.K468Efs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	521/3056	p.E522Ifs*43	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	522/3056	p.E522*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	633/3056	p.X633_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Ins	639/3056	p.D639Vfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	644/3056	p.S644*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	704/3056	p.Y705Tfs*30	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Region	750/3056	p.K750=	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	793/3056	p.X793_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	805/3056	p.R805*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Ins	834/3056	p.V835Sfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	852/3056	p.Q852*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	876/3056	p.S877Vfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	927/3056	p.L927*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Missense_Mutation	950/3056	p.L950R	SAMPLE			True	True	Unknown																			
ATM	Nonsense_Mutation	959/3056	p.Y959*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	974/3056	p.X974_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Ins	1028/3056	p.T1029Nfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	1052/3056	p.X1052_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	1080-1081/3056	p.N1081Ifs*27	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Ins	1082/3056	p.H1082Lfs*28	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	1083/3056	p.H1083Tfs*26	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	1094/3056	p.N1094Ifs*15	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	1097/3056	p.Q1098Rfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	1114/3056	p.K1114*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	1134/3056	p.X1134_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Region	1192/3056	p.K1192=	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	1192/3056	p.X1192_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	1209/3056	p.F1209Yfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	1221/3056	p.W1221*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	1223-1224/3056	p.N1223_L1224ins*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	1235-1237/3056	p.L1238Kfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	1267/3056	p.E1267*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	1267/3056	p.V1268*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Ins	1312/3056	p.E1313Rfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	1412/3056	p.X1412_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	1466/3056	p.R1466*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Ins	1579/3056	p.I1581Nfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	1663/3056	p.G1663Vfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	1730/3056	p.R1730*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	1764/3056	p.L1764Yfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	1839/3056	p.Q1839*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	1849/3056	p.L1850Yfs*67	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	1875/3056	p.R1875*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	1877-1878/3056	p.S1878Kfs*38	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	1882/3056	p.R1882*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	1898/3056	p.R1898*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Ins	1902-1903/3056	p.S1905Ifs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	1970/3056	p.Q1970*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	1978/3056	p.E1978*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	21514219;18807267;32343890								
ATM	Frame_Shift_Ins	2005/3056	p.E2007Rfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Missense_Mutation	2032/3056	p.R2032K	SAMPLE			True	True	Inconclusive	Inconclusive										25614872;22585167;16266405;27159176;10980530								
ATM	Nonsense_Mutation	2034/3056	p.R2034*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2036/3056	p.Y2036*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2058/3056	p.S2058*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	2076/3056	p.L2077Ffs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2097/3056	p.E2097*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2196/3056	p.R2196*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Ins	2224/3056	p.A2225Gfs*24	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Missense_Mutation	2227/3056	p.R2227C	SAMPLE			True	False	Unknown																			
ATM	Frame_Shift_Del	2252/3056	p.T2252Pfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	2305/3056	p.L2307Cfs*65	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Ins	2332-2333/3056	p.T2333Nfs*40	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	2337/3056	p.C2337Sfs*35	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Missense_Mutation	2424/3056	p.V2424G	SAMPLE			True	True	Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	17001622;18634022;32343890								
ATM	Splice_Site	2436/3056	p.X2436_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2443/3056	p.R2443*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2486/3056	p.R2486*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	?-2506/3056	p.X2506_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	2544/3056	p.X2544_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	2556-2557/3056	p.F2558Lfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Region	2596/3056	p.E2596=	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	2596/3056	p.X2596_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2638/3056	p.W2638*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2641/3056	p.Q2641*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	2679-2684/3056	p.N2679Sfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	2701-2702/3056	p.I2702Rfs*15	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Ins	2712/3056	p.R2713Efs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2714/3056	p.Q2714*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Missense_Mutation	2716/3056	p.V2716A	SAMPLE			True	False	Unknown																			
ATM	Nonsense_Mutation	2729/3056	p.Q2729*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	2755-2756/3056	p.Y2755Cfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2756/3056	p.K2756*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2769/3056	p.W2769*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	2795-2798/3056	p.F2799Kfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	2806/3056	p.X2806_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	2809/3056	p.K2811Sfs*46	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	2814/3056	p.E2814Kfs*43	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Splice_Site	2929/3056	p.X2929_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2931/3056	p.C2931*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	2938-2942/3056	p.M2938Ifs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Frame_Shift_Del	2944/3056	p.L2945Vfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2960/3056	p.W2960*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Nonsense_Mutation	2993/3056	p.R2993*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	30553448;27413114;30348496;32343890								
ATM	Missense_Mutation	3008/3056	p.R3008C	SAMPLE	Y		True	True	Loss-of-function	Oncogenic	Olaparib,Olaparib								LEVEL_1	11756177;12552566;23585524;32343890								
ATM	Missense_Mutation	3008/3056	p.R3008H	SAMPLE	Y		True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	11756177;23585524;30696305;12149228;32343890								
ATM	Nonsense_Mutation	3047/3056	p.R3047*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	19431188;32343890								
ATR	Nonsense_Mutation	2177/2644	p.W2177*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Splice_Site	2107/2644	p.X2107_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Frame_Shift_Ins	2013/2644	p.T2013Nfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Nonsense_Mutation	1886/2644	p.R1886*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Nonsense_Mutation	1653/2644	p.R1653*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Frame_Shift_Ins	1640/2644	p.T1640Rfs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Nonsense_Mutation	1627/2644	p.Q1627*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Splice_Site	1461/2644	p.X1461_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Nonsense_Mutation	1412/2644	p.R1412*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Nonsense_Mutation	1183/2644	p.R1183*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Splice_Site	1120/2644	p.X1120_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Frame_Shift_Del	926/2644	p.F926Sfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Splice_Site	878/2644	p.X878_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Frame_Shift_Del	774/2644	p.I774Yfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Nonsense_Mutation	757/2644	p.Q757*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Nonsense_Mutation	635/2644	p.R635*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Frame_Shift_Del	453/2644	p.H453Rfs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Frame_Shift_Ins	228-229/2644	p.L229Tfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Nonsense_Mutation	190/2644	p.Q190*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
ATR	Nonsense_Mutation	62/2644	p.Q62*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15282542;10691732								
AXIN1	Splice_Site	765/862	p.X765_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25236910;10700176								
AXIN1	Splice_Site	765-?/862	p.X765_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25236910;10700176								
AXIN1	Nonsense_Mutation	733/862	p.E733*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25236910;10700176								
AXIN1	Nonsense_Mutation	732/862	p.Q732*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25236910;10700176								
AXIN1	Splice_Site	595/862	p.X595_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25236910;10700176								
AXIN1	Frame_Shift_Ins	534/862	p.H534Qfs*57	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25236910;10700176								
AXIN1	Frame_Shift_Del	242-243/862	p.N242Rfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25236910;10700176								
AXIN1	Frame_Shift_Del	78/862	p.T79Pfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25236910;10700176								
AXIN2	Nonsense_Mutation	713/843	p.Q713*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15802015;17373666								
AXIN2	Splice_Site	636/843	p.X636_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15802015;17373666								
AXIN2	Nonsense_Mutation	580/843	p.K580*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15802015;17373666								
BAP1	Nonsense_Mutation	671/729	p.Y671*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Del	671/729	p.Y671Sfs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Splice_Site	661/729	p.X661_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Nonsense_Mutation	593/729	p.Q593*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Del	573/729	p.L573Wfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Del	559-562/729	p.T559Cfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Del	492/729	p.S492Yfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Del	460/729	p.S460Nfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Del	423-425/729	p.T423Sfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Nonsense_Mutation	418/729	p.Y418*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Nonsense_Mutation	401/729	p.Y401*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Nonsense_Mutation	395/729	p.S395*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Del	392/729	p.Q392Sfs*38	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Ins	370-371/729	p.M371Hfs*27	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Del	346/729	p.H347Tfs*15	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Del	275/729	p.K275Sfs*60	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Splice_Site	262/729	p.X262_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Splice_Site	258-?/729	p.X258_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Ins	209/729	p.V209Gfs*34	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Nonsense_Mutation	196/729	p.W196*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Splice_Site	194/729	p.X194_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Nonsense_Mutation	148/729	p.E148*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Splice_Site	146/729	p.X146_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Del	49/729	p.L49Cfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BAP1	Frame_Shift_Del	40/729	p.Q40Rfs*32	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21874000;18757409								
BARD1	Splice_Site	668/777	p.X668_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Nonsense_Mutation	649/777	p.E649*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Nonsense_Mutation	641/777	p.R641*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Frame_Shift_Del	606/777	p.H606Rfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Frame_Shift_Del	578/777	p.S578Lfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Nonsense_Mutation	564/777	p.Q564*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Nonsense_Mutation	551/777	p.S551*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Nonsense_Mutation	406/777	p.R406*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Nonsense_Mutation	371/777	p.K371*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Frame_Shift_Del	341/777	p.S342Afs*58	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Frame_Shift_Del	325-326/777	p.H325Qfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Frame_Shift_Del	287/777	p.E287Vfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Frame_Shift_Del	209-210/777	p.K209Nfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Frame_Shift_Ins	205/777	p.Q206Afs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Frame_Shift_Del	180/777	p.Y180*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Nonsense_Mutation	150/777	p.R150*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Nonsense_Mutation	112/777	p.R112*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Nonsense_Mutation	78/777	p.C78*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Frame_Shift_Del	76/777	p.S76Vfs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BARD1	Translation_Start_Site	1/777	p.M1?	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20029420;8944023;32343890								
BBC3	Frame_Shift_Ins	242/261	p.R243Qfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										17178918;14500851;14585359;23220852;15192153;11572983								
BBC3	Nonsense_Mutation	223/261	p.R223*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										17178918;14500851;14585359;23220852;15192153;11572983								
BBC3	Nonsense_Mutation	207/261	p.Q207*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										17178918;14500851;14585359;23220852;15192153;11572983								
BCL10	Frame_Shift_Del	92/233	p.Q92Efs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9989495;10319863								
BCL2L11	Nonsense_Mutation	29/198	p.R29*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24737648;23382048;26076815;23559152;21652541;26001141;23116058								
BCL2L11	Frame_Shift_Del	34/198	p.S35Pfs*49	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24737648;23382048;26076815;23559152;21652541;26001141;23116058								
BCL2L11	Nonsense_Mutation	122/198	p.Q122*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24737648;23382048;26076815;23559152;21652541;26001141;23116058								
BCL2L11	Splice_Site	166/198	p.X166_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24737648;23382048;26076815;23559152;21652541;26001141;23116058								
BCOR	Frame_Shift_Ins	838-839/1755	p.K839Qfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26847029;22012066;25550361;22237022;24047651		CMML,MDS		LEVEL_Dx2				
BCOR	Frame_Shift_Del	107/1755	p.S107Afs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26847029;22012066;25550361;22237022;24047651		CMML,MDS		LEVEL_Dx2				
BLM	Splice_Site	33/1417	p.X33_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	71/1417	p.S72Lfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	99/1417	p.Q100Efs*42	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Ins	106-107/1417	p.L107Ffs*36	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	200-201/1417	p.N202Qfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	256-257/1417	p.L258Efs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	361/1417	p.C361*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	469-470/1417	p.T471Pfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Ins	512/1417	p.N515Kfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Nonsense_Mutation	548/1417	p.Q548*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Nonsense_Mutation	567/1417	p.W567*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Nonsense_Mutation	595/1417	p.S595*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	597-598/1417	p.E598Dfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Nonsense_Mutation	645/1417	p.Q645*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Ins	656/1417	p.K657Efs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	695/1417	p.S696Ffs*44	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Splice_Site	731-?/1417	p.X731_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Nonsense_Mutation	736/1417	p.Y736*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Ins	750-751/1417	p.L751Kfs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Nonsense_Mutation	864/1417	p.Y864*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Nonsense_Mutation	881/1417	p.W881*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Nonsense_Mutation	899/1417	p.R899*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Nonsense_Mutation	934/1417	p.W934*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	950-952/1417	p.M951Lfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Missense_Mutation	952/1417	p.G952V	SAMPLE			True	False	Unknown																			
BLM	Nonsense_Mutation	959/1417	p.R959*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	974/1417	p.Q975Kfs*24	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	1010/1417	p.D1010Mfs*24	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Missense_Mutation	1055/1417	p.C1055S	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										11399766;10069810;17407155								
BLM	Splice_Site	1070/1417	p.X1070_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Nonsense_Mutation	1127/1417	p.Q1127*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Nonsense_Mutation	1139/1417	p.R1139*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	1145/1417	p.F1146*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	1159/1417	p.L1159Ifs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	1179/1417	p.V1180Yfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Del	1188/1417	p.F1189Lfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Frame_Shift_Ins	1189-1190/1417	p.M1190Nfs*27	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BLM	Nonsense_Mutation	1280/1417	p.S1280*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26358404;11532193								
BRAF	Missense_Mutation	594/766	p.D594N	SAMPLE	Y	Y	True	True	Gain-of-function	Oncogenic			Cobimetinib						LEVEL_3A	23833300;26498038;28783719;22798288;Noeparast et al. Abstract# 11091, ASCO 2015(http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/11091);30718231;29236635;30867592			ETPLL	LEVEL_Dx3				
BRCA1	Nonsense_Mutation	1853/1863	p.Y1853*	SAMPLE			True	True	Loss-of-function	Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	15004537;14729053;8942979;15569676;21922593;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1835/1863	p.R1835*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1785/1863	p.Q1785*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1779/1863	p.Q1779Nfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	1775/1863	p.M1775R	SAMPLE			True	True	Loss-of-function	Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	15004537;14729053;10811118;12427738;7545954;8751436;16101277;11573086;15689452;15569676;8942979;10635334;23161852;15133502;7939630;15172985;20516115;21922593;9159158;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Ins	1773-1774/1863	p.N1774Qfs*56	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Ins	1756/1863	p.Q1756Pfs*74	SAMPLE			True	False	Likely Loss-of-function	Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1751/1863	p.R1751*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Splice_Site	1732/1863	p.X1732_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1731/1863	p.E1731*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1726-1727/1863	p.R1726Kfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1727/1863	p.K1727*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	1708/1863	p.A1708E	SAMPLE			True	True	Loss-of-function	Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	15172985;23867111;8751436;11573086;15923272;8942979;20516115;21922593;11157798;9159158;7939630;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	1699/1863	p.R1699W	SAMPLE			True	True	Loss-of-function	Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	15172985;23867111;11573086;12496476;20516115;11157798;7939630;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	1692/1863	p.D1692H	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	25724305;20516115;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1667/1863	p.K1667*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1655-1661/1863	p.S1655Yfs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1646/1863	p.V1646Sfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1612/1863	p.Q1612*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1572/1863	p.D1573Mfs*28	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1563/1863	p.Y1563*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1542/1863	p.S1542Wfs*31	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1525/1863	p.Q1525Rfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1518/1863	p.Q1518*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1508/1863	p.W1508*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Splice_Site	1495/1863	p.X1495_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	1495/1863	p.R1495M	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	23633455;27741520;22762150;22711857;29875428;22505045;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1465/1863	p.I1465*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Splice_Site	1453/1863	p.X1453_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1452/1863	p.K1452*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Ins	1446-1447/1863	p.Q1447Rfs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1443/1863	p.R1443*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1431/1863	p.I1432Sfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1417/1863	p.V1417Gfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1408/1863	p.Q1408*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1395/1863	p.Q1395*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1379/1863	p.S1379*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1374/1863	p.S1374*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Splice_Site	1366/1863	p.X1366_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1363/1863	p.S1363*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1355-1356/1863	p.N1355Kfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1345/1863	p.E1346Kfs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1302/1863	p.E1302*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1298/1863	p.S1298*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1257/1863	p.E1257Gfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Ins	1255/1863	p.N1255Kfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Ins	1254/1863	p.K1254Nfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1252-1253/1863	p.S1253Rfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1245/1863	p.S1245Tfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1203/1863	p.R1203*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1200/1863	p.Q1200*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1161-1164/1863	p.E1161Ffs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	1138/1863	p.G1138*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1120/1863	p.V1120*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1111-1112/1863	p.Q1111Nfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	1076-1077/1863	p.G1077Afs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Ins	985-986/1863	p.I986Hfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	978/1863	p.Y978*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Ins	945-946/1863	p.I946Yfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	936-937/1863	p.D936Sfs*63	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	922/1863	p.V923Lfs*77	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	920/1863	p.Q921Rfs*79	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	908/1863	p.E908*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Ins	903/1863	p.C903Yfs*98	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	894/1863	p.K894Tfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	879/1863	p.E879*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	819/1863	p.D821Ifs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	804/1863	p.Q804Lfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	797/1863	p.E797Tfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	797/1863	p.E797*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	770/1863	p.S770*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	679/1863	p.K679*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	672/1863	p.K672*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	654/1863	p.K654Sfs*47	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Ins	651-652/1863	p.K652Efs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	563/1863	p.Q563*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	558/1863	p.G559Vfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	505/1863	p.K505*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	372/1863	p.W372*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	347/1863	p.L347Vfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Ins	339/1863	p.V340Gfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	327-328/1863	p.C328*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	308/1863	p.S308Kfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	281-282/1863	p.S282Yfs*15	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Ins	275/1863	p.T276Afs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	266-267/1863	p.S267Kfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	265/1863	p.S265Cfs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Ins	236/1863	p.T236Nfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	226/1863	p.C226Vfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Splice_Site	224/1863	p.X224_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Splice_Site	198/1863	p.X198_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Splice_Site	183/1863	p.X183_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Frame_Shift_Del	172/1863	p.Q172Nfs*62	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	169/1863	p.Q169*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Splice_Site	148/1863	p.X148_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Splice_Site	147/1863	p.X147_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	143/1863	p.E143*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	101/1863	p.Y101*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Splice_Site	101/1863	p.X101_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Splice_Site	71/1863	p.X71_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	64/1863	p.C64Y	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	20103620;10635334;23867111;23161852;16403807;22034435;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	64/1863	p.C64G	SAMPLE			True	True	Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	20103620;10635334;23867111;23161852;16403807;22034435;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	63/1863	p.L63*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	61/1863	p.C61Y	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	14729053;20103620;23867111;22034435;15569676;23161852;16403807;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	61/1863	p.C61G	SAMPLE			True	True	Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	14729053;20103620;23867111;22034435;15569676;23161852;16403807;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Splice_Site	45/1863	p.X45_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Nonsense_Mutation	45/1863	p.K45*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	41/1863	p.H41R	SAMPLE			True	True	Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	20103620;23161852;16403807;22034435;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	39/1863	p.C39Y	SAMPLE			True	True	Loss-of-function	Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	20103620;23161852;21922593;16403807;22034435;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	39/1863	p.C39R	SAMPLE			True	True	Inconclusive	Inconclusive										16403807;22034435								
BRCA1	Frame_Shift_Del	23/1863	p.E23Vfs*17	SAMPLE			True	False	Likely Loss-of-function	Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	11358863;20608970;12483515;12947386;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA1	Missense_Mutation	22/1863	p.L22S	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Olaparib,Olaparib						LEVEL_1	9609997;19543972;21990134;24489791;25366685;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);28578601;Pascual et al. JCOPO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00012);31157963;32444418								
BRCA2	Frame_Shift_Del	9/3418	p.P9Qfs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Splice_Site	23/3418	p.X23_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	80-81/3418	p.I80Kfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	97/3418	p.E97*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	135/3418	p.N136Ifs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Splice_Site	159/3418	p.X159_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Splice_Site	173/3418	p.X173_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Missense_Mutation	211/3418	p.V211I	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	23451180;22962691;19179552;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	219-220/3418	p.V220Ifs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	250-251/3418	p.D252Vfs*24	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Splice_Site	265/3418	p.X265_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	273/3418	p.S273*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	342/3418	p.K343Nfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	379/3418	p.S380Vfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	385/3418	p.K385*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	397/3418	p.Q397Lfs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	407/3418	p.Q407*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	413/3418	p.L413Hfs*17	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	434-435/3418	p.K437Ifs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	462/3418	p.E462*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	463-464/3418	p.V464Gfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	467/3418	p.D469*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	486/3418	p.Q486*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	499/3418	p.G500Vfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	510/3418	p.E510*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	541/3418	p.E541*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	557/3418	p.L557*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	563/3418	p.W563Cfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	583/3418	p.L583*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	584/3418	p.K585Rfs*29	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	598-600/3418	p.S599*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	600/3418	p.Y600*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	602/3418	p.I605Nfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	617/3418	p.S617*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	629-631/3418	p.T630Qfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Splice_Site	637/3418	p.X637_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	643/3418	p.R645Efs*15	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	682-683/3418	p.S683Rfs*46	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	698/3418	p.L698Yfs*32	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	698/3418	p.Q699Sfs*31	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	700/3418	p.L700*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	717/3418	p.C717*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	738/3418	p.C738*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	759/3418	p.L760Ifs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	777/3418	p.D777Efs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	790/3418	p.E790*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	792-793/3418	p.M794Nfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	799/3418	p.L809Vfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	871/3418	p.S871*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	873/3418	p.I873Nfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	901/3418	p.A902Lfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	928/3418	p.L929Yfs*31	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	936-937/3418	p.A938Pfs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	940/3418	p.Q940*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	944/3418	p.K944*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	946/3418	p.D946Ifs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1021-1022/3418	p.N1023*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1026/3418	p.K1026*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1037/3418	p.Q1037*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1064-1065/3418	p.N1066Lfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1072/3418	p.L1072*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	1088/3418	p.Q1089Sfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1112/3418	p.T1112Kfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	1140/3418	p.T1141Yfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1182/3418	p.F1182*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1230/3418	p.S1230Lfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1241/3418	p.F1241Lfs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1282-1283/3418	p.V1283Kfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1286-1287/3418	p.N1287Ifs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1289/3418	p.K1289_C1290ins*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1308/3418	p.E1308*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1335/3418	p.E1335*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	1335/3418	p.F1336Ifs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1343-1345/3418	p.N1344Yfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1353-1354/3418	p.E1353Gfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1377-1378/3418	p.N1377_T1378ins*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1408/3418	p.Q1408*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	1426-1427/3418	p.Q1429Sfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1465-1467/3418	p.L1466Ffs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1483/3418	p.D1484Tfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1491-1492/3418	p.L1491Qfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	1529-1530/3418	p.V1532Sfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1543/3418	p.N1544Tfs*24	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1545/3418	p.F1546Lfs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	1572/3418	p.A1572Gfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1573/3418	p.C1573*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1609-1610/3418	p.V1610Gfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1645-1646/3418	p.E1646Qfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1658/3418	p.Q1658Hfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	1689/3418	p.W1692Mfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1694-1695/3418	p.R1694Kfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1702-1703/3418	p.R1704*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1704-1705/3418	p.N1706Lfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1710-1711/3418	p.Y1710*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1715-1716/3418	p.Y1716Kfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	1719/3418	p.S1720Ffs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1720/3418	p.S1720*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1720/3418	p.N1721Tfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1737-1738/3418	p.T1738Ifs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1739-1741/3418	p.Y1739*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1740-1741/3418	p.S1741Tfs*35	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	1746/3418	p.N1747*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1760/3418	p.S1760*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1764/3418	p.S1764*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1782/3418	p.N1784Hfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	1788/3418	p.K1789Qfs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1821/3418	p.N1822Ifs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1857/3418	p.E1857Kfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1858-1859/3418	p.I1859Kfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1868/3418	p.D1868Efs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1872/3418	p.K1872*	SAMPLE			True	True	Inconclusive	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	28450426;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1882/3418	p.S1882*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1894/3418	p.Y1894*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1906-1907/3418	p.L1908Rfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1922/3418	p.A1922Lfs*41	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1925/3418	p.Q1925Efs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1928/3418	p.E1928*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1930/3418	p.L1930*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1932/3418	p.H1932Qfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1933-1934/3418	p.N1933Kfs*29	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1941/3418	p.K1941Sfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1942/3418	p.S1943*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1950-1951/3418	p.S1951Wfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1953/3418	p.E1953*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	1955/3418	p.S1955*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	1982/3418	p.S1982Rfs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2003-2005/3418	p.E2004Vfs*34	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2013/3418	p.K2013*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2026-2028/3418	p.E2028Kfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	2031/3418	p.I2033Cfs*17	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2087/3418	p.R2087Efs*32	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2092/3418	p.L2092Pfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2093-2096/3418	p.S2095Vfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2123/3418	p.T2125Pfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2127/3418	p.S2127Vfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2134-2136/3418	p.N2135Kfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	2148/3418	p.I2149Yfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2149-2150/3418	p.I2149Sfs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2154/3418	p.Y2154*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2154-2155/3418	p.Q2157Ifs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2161-2162/3418	p.K2162Nfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2164-2165/3418	p.Q2164Rfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2197-2198/3418	p.E2198Nfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2199-2200/3418	p.S2201*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2210/3418	p.E2210Gfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2215-2216/3418	p.Y2215Sfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2219/3418	p.S2219*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2295-2296/3418	p.R2295Nfs*43	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2318/3418	p.R2318*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Missense_Mutation	2336/3418	p.R2336H	SAMPLE			True	True	Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	18451181;17924331;18489799;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Missense_Mutation	2336/3418	p.R2336P	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	22505045;9150172;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Splice_Site	2336/3418	p.X2336_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2354/3418	p.Q2354*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2378/3418	p.S2378*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2481/3418	p.T2482Qfs*42	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2494/3418	p.R2494*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	2514/3418	p.T2517Kfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2520/3418	p.R2520*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2561/3418	p.Q2561*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2573/3418	p.L2573*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2581-2583/3418	p.A2582Vfs*64	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2588/3418	p.I2588Yfs*60	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Missense_Mutation	2626/3418	p.W2626C	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	17924331;29394989;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2626/3418	p.W2626*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Missense_Mutation	2627/3418	p.I2627F	SAMPLE			True	True	Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	18451181;17924331;29394989;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2637-2638/3418	p.F2638*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2640-2643/3418	p.K2640Ifs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Splice_Site	2659/3418	p.X2659_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	2662/3418	p.E2663Gfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2686/3418	p.V2687Ffs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Missense_Mutation	2723/3418	p.D2723H	SAMPLE			True	True	Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	15695382;29394989;16489001;18451181;15290653;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Missense_Mutation	2748/3418	p.G2748D	SAMPLE			True	True	Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	18451181;17924331;29394989;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2749/3418	p.K2750Dfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2766/3418	p.T2766Nfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2774/3418	p.M2775Cfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2776/3418	p.L2776*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2776/3418	p.K2777Rfs*44	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Splice_Site	2777/3418	p.X2777_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Splice_Site	2829/3418	p.X2829_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2830/3418	p.W2830*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2845/3418	p.E2846Gfs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2859/3418	p.Q2859Kfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2899/3418	p.Q2899*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	2957/3418	p.Q2957*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Splice_Site	2985/3418	p.X2985_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	2987-2988/3418	p.S2988Ffs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	3009-3010/3418	p.Y3009Sfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	3024-3025/3418	p.N3024Yfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	3030/3418	p.T3033Nfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	3030/3418	p.T3033Lfs*29	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Splice_Region	3039/3418	p.P3039=	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	3050/3418	p.Q3050*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	3066/3418	p.Q3066*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	3076/3418	p.G3076Dfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	3082-3083/3418	p.T3085Nfs*26	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	3083/3418	p.T3085Qfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Splice_Site	3086/3418	p.X3086_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	3092/3418	p.Y3092*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Missense_Mutation	3095/3418	p.D3095E	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	18451181;17924331;29394989;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	3128/3418	p.R3128*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	3134/3418	p.L3135Ffs*28	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	3144-3145/3418	p.S3147Cfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	3152/3418	p.G3153Afs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Del	3200/3418	p.S3200*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Nonsense_Mutation	3200/3418	p.S3200*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRCA2	Frame_Shift_Ins	3249/3418	p.S3250Ffs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib,Olaparib,Olaparib,Olaparib,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Olaparib+Bevacizumab,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Rucaparib,Niraparib,Niraparib,Niraparib	Talazoparib,Olaparib	Rucaparib,Rucaparib,Olaparib,Olaparib						LEVEL_1	24312913;11239455;22193408;20878484;10570174;25366685;30285518;30345884;24882434;Penson et al. Abstract# 5506, ASCO 2019(https://meetinglibrary.asco.org/record/173435/abstract);26510020;32343890;Abida et al. Abstract# 846PD, ESMO 2019(https://www.sciencedirect.com/science/article/pii/S0923753419590627);Abida et al. JCO, Aug 2020(https://ascopubs.org/doi/full/10.1200/JCO.20.01035);28882436;28916367;32359490;30425037;30948273;27717299;31562799;30110579;30563931;28578601;Dhawan, MS et al. JCO. Abstract# 2527(https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2527);17444865;30051098;Reiss Binder et al. Abstract# CT234, AACR 2019(https://cancerres.aacrjournals.org/content/79/13_Supplement/CT234);31157963;32444418								
BRIP1	Frame_Shift_Del	1134/1249	p.P1134Lfs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Del	1130-1131/1249	p.Y1131Lfs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Ins	1002/1249	p.W1002Lfs*60	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Del	998-999/1249	p.K998Efs*60	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Del	997-998/1249	p.T997Rfs*61	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Ins	972/1249	p.F973Sfs*30	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Nonsense_Mutation	930/1249	p.S930*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Nonsense_Mutation	922/1249	p.L922*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Ins	918/1249	p.S919Lfs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Del	895-896/1249	p.S895*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Splice_Site	859/1249	p.X859_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Nonsense_Mutation	800/1249	p.Y800*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Nonsense_Mutation	798/1249	p.R798*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;17033622;32343890								
BRIP1	Frame_Shift_Del	752/1249	p.K752Rfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Ins	703/1249	p.K703Nfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Nonsense_Mutation	624/1249	p.S624*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Nonsense_Mutation	581/1249	p.R581*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Ins	576/1249	p.N576Kfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Del	541/1249	p.N541Ifs*49	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Nonsense_Mutation	448/1249	p.W448*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Nonsense_Mutation	439/1249	p.R439*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Del	412/1249	p.V413Ffs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Ins	402/1249	p.A402Vfs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Nonsense_Mutation	353/1249	p.Y353*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Missense_Mutation	349/1249	p.A349P	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16116424;20639400;32343890								
BRIP1	Splice_Site	306/1249	p.X306_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Splice_Site	170/1249	p.X170_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Del	151/1249	p.N151Mfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Nonsense_Mutation	147/1249	p.Y147*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Ins	132/1249	p.T132Nfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Del	47/1249	p.T48Qfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Nonsense_Mutation	35/1249	p.G35*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Splice_Site	31/1249	p.X31_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
BRIP1	Frame_Shift_Ins	19/1249	p.Y19Lfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16153896;21964575;24040146;17033622;18628483;32343890								
CASP8	Frame_Shift_Ins	15-16/538	p.G20Tfs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15531912;15705878;12949717;19852930								
CASP8	Frame_Shift_Del	33-34/538	p.G34Qfs*24	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15531912;15705878;12949717;19852930								
CASP8	Frame_Shift_Del	39/538	p.E40Rfs*45	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15531912;15705878;12949717;19852930								
CASP8	Splice_Site	51/538	p.X51_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15531912;15705878;12949717;19852930								
CASP8	Splice_Site	258/538	p.X258_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15531912;15705878;12949717;19852930								
CASP8	Splice_Site	279/538	p.X279_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15531912;15705878;12949717;19852930								
CASP8	Frame_Shift_Ins	337/538	p.H337Lfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15531912;15705878;12949717;19852930								
CASP8	Nonsense_Mutation	439/538	p.Y439*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15531912;15705878;12949717;19852930								
CASP8	Nonsense_Mutation	448/538	p.Q448*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15531912;15705878;12949717;19852930								
CASP8	Frame_Shift_Del	508-509/538	p.V509Afs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15531912;15705878;12949717;19852930								
CBL	Nonsense_Mutation	34/906	p.Q34*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22315494;20508043;20694012		CMML,JMML,MDS		LEVEL_Dx2	MDS			LEVEL_Px1
CBL	Frame_Shift_Del	343-344/906	p.R343Lfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22315494;20508043;20694012		CMML,JMML,MDS		LEVEL_Dx2	MDS			LEVEL_Px1
CBL	Nonsense_Mutation	420/906	p.R420*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22315494;20508043;20694012		CMML,JMML,MDS		LEVEL_Dx2	MDS			LEVEL_Px1
CBL	Nonsense_Mutation	609/906	p.W609*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22315494;20508043;20694012		CMML,JMML,MDS		LEVEL_Dx2	MDS			LEVEL_Px1
CBL	Splice_Site	679/906	p.X679_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22315494;20508043;20694012		CMML,JMML,MDS		LEVEL_Dx2	MDS			LEVEL_Px1
CBL	Frame_Shift_Del	740/906	p.A741Rfs*125	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22315494;20508043;20694012		CMML,JMML,MDS		LEVEL_Dx2	MDS			LEVEL_Px1
CBL	Splice_Site	812/906	p.X812_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22315494;20508043;20694012		CMML,JMML,MDS		LEVEL_Dx2	MDS			LEVEL_Px1
CDC73	Frame_Shift_Del	173-174/531	p.S174Kfs*27	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15531515;12960210								
CDH1	Splice_Site	129/882	p.X129_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8934538;17522512								
CDH1	Splice_Site	178/882	p.X178_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8934538;17522512								
CDH1	Splice_Site	522/882	p.X522_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8934538;17522512								
CDH1	Frame_Shift_Ins	651/882	p.L652Ffs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8934538;17522512								
CDH1	Frame_Shift_Del	662-666/882	p.Y663Sfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8934538;17522512								
CDH1	Frame_Shift_Del	667/882	p.L667Sfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8934538;17522512								
CDH1	Nonsense_Mutation	699/882	p.Q699*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8934538;17522512								
CDH1	Nonsense_Mutation	763/882	p.E763*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8934538;17522512								
CDH1	Frame_Shift_Del	775-779/882	p.D777Kfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8934538;17522512								
CDK12	Nonsense_Mutation	233/1490	p.Q233*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib				Pembrolizumab,Nivolumab,Cemiplimab				LEVEL_1	24554720;21720365;25712099;26787825;32343890;29906450								
CDK4	Missense_Mutation	24/303	p.R24H	SAMPLE	Y	Y	True	True	Likely Gain-of-function	Likely Oncogenic										11756559;11606789								
CDK6	Missense_Mutation	197/326	p.A197T	SAMPLE			True	True	Loss-of-function	Likely Neutral										23918663								
CDKN1A	Frame_Shift_Del	14/164	p.G14Afs*17	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23624841;24317508;19106607;24777035								
CDKN1A	Frame_Shift_Del	34/164	p.C34Vfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23624841;24317508;19106607;24777035								
CDKN1A	Nonsense_Mutation	84/164	p.R84*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23624841;24317508;19106607;24777035								
CDKN1B	Frame_Shift_Del	124-125/198	p.S125*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8646779;17519308;23460367;25416039								
CDKN1B	Frame_Shift_Del	163-164/198	p.N164Kfs*39	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8646779;17519308;23460367;25416039								
CDKN1B	Nonstop_Mutation	199/198	p.*199Eext*60	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8646779;17519308;23460367;25416039								
CDKN2A	Missense_Mutation	153/156	p.D153Y	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					Palbociclib,Ribociclib,Abemaciclib				LEVEL_4	12853981;19874578;24495407;25941111;29232554;28283584								
CDKN2A	Frame_Shift_Del	114-119/156	p.P114Rfs*27	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					Palbociclib,Ribociclib,Abemaciclib				LEVEL_4	8668202;8603820;Fostira et al. JCO PO, 2018(http://ascopubs.org/doi/full/10.1200/PO.18.00022);19874578;24495407;25941111;29232554;28283584								
CDKN2A	In_Frame_Ins	113/156	p.R112dup	SAMPLE			True	False	Unknown																			
CDKN2A	Nonsense_Mutation	164/173	p.C164*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					Palbociclib,Ribociclib,Abemaciclib				LEVEL_4	8668202;8603820;Fostira et al. JCO PO, 2018(http://ascopubs.org/doi/full/10.1200/PO.18.00022);19874578;24495407;25941111;29232554;28283584								
CDKN2A	Nonsense_Mutation	124/173	p.G124*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					Palbociclib,Ribociclib,Abemaciclib				LEVEL_4	8668202;8603820;Fostira et al. JCO PO, 2018(http://ascopubs.org/doi/full/10.1200/PO.18.00022);19874578;24495407;25941111;29232554;28283584								
CDKN2A	Missense_Mutation	59/156	p.V59G	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic					Palbociclib,Ribociclib,Abemaciclib				LEVEL_4	25780468;21893440;22841127;12700603;10874641;19874578;24495407;25941111;29232554;28283584								
CDKN2A	Nonsense_Mutation	26/156	p.E26*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					Palbociclib,Ribociclib,Abemaciclib				LEVEL_4	8668202;8603820;Fostira et al. JCO PO, 2018(http://ascopubs.org/doi/full/10.1200/PO.18.00022);19874578;24495407;25941111;29232554;28283584								
CDKN2A	Missense_Mutation	24/156	p.R24P	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic					Palbociclib,Ribociclib,Abemaciclib				LEVEL_4	15146471;9328469;20340136;9516223;19874578;24495407;25941111;29232554;28283584								
CDKN2B	Frame_Shift_Del	115/138	p.L115Rfs*50	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28892048;25873077;26183406;11485924								
CDKN2B	Frame_Shift_Ins	102-103/138	p.G103Rfs*60	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28892048;25873077;26183406;11485924								
CDKN2B	Splice_Site	53/138	p.X53_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28892048;25873077;26183406;11485924								
CHEK1	Splice_Site	22/476	p.X22_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	18716058;12124347;14681223;23508805;10757443;10859164;11691784;32343890								
CHEK1	Frame_Shift_Del	108/476	p.R109Ifs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	18716058;12124347;14681223;23508805;10757443;10859164;11691784;32343890								
CHEK1	Nonsense_Mutation	217/476	p.E217*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	18716058;12124347;14681223;23508805;10757443;10859164;11691784;32343890								
CHEK1	Frame_Shift_Ins	223/476	p.T226Nfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	18716058;12124347;14681223;23508805;10757443;10859164;11691784;32343890								
CHEK1	Frame_Shift_Ins	223/476	p.T226Kfs*15	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	18716058;12124347;14681223;23508805;10757443;10859164;11691784;32343890								
CHEK1	Nonsense_Mutation	224/476	p.K224*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	18716058;12124347;14681223;23508805;10757443;10859164;11691784;32343890								
CHEK1	Nonsense_Mutation	277/476	p.R277*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	18716058;12124347;14681223;23508805;10757443;10859164;11691784;32343890								
CHEK1	Frame_Shift_Del	284-285/476	p.E285Vfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	18716058;12124347;14681223;23508805;10757443;10859164;11691784;32343890								
CHEK1	Nonsense_Mutation	346/476	p.Q346*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	18716058;12124347;14681223;23508805;10757443;10859164;11691784;32343890								
CHEK1	Nonsense_Mutation	379/476	p.R379*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	18716058;12124347;14681223;23508805;10757443;10859164;11691784;32343890								
CHEK2	Frame_Shift_Del	478/543	p.E479Kfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Ins	456-457/543	p.E457Rfs*33	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	446/543	p.N446Tfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Nonsense_Mutation	433/543	p.Q433*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Nonsense_Mutation	411/543	p.W411*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	404-407/543	p.Y404Lfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	380/543	p.L380Hfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	367/543	p.T367Mfs*15	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Nonsense_Mutation	336/543	p.Q336*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Nonsense_Mutation	327/543	p.Y327*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	318/543	p.R318Afs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	292/543	p.F292Lfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	292/543	p.F292*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Splice_Site	282/543	p.X282_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Splice_Site	265/543	p.X265_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Nonsense_Mutation	245/543	p.K245*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Splice_Site	198/543	p.X198_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	197/543	p.V198Ffs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Ins	175/543	p.G176*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	169/543	p.F169Lfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Splice_Site	148/543	p.X148_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Missense_Mutation	145/543	p.R145W	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16982735;11571648;22419737;11719428;15535844;11390408;11298456;12049740;32343890								
CHEK2	Nonsense_Mutation	139/543	p.Y139*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Missense_Mutation	117/543	p.R117G	SAMPLE			True	True	Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	16835864;16982735;32343890								
CHEK2	Nonsense_Mutation	95/543	p.R95*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	94/543	p.R95Dfs*15	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	93/543	p.W93Gfs*17	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	92/543	p.W93Gfs*17	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	74/543	p.P75Lfs*35	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Nonsense_Mutation	72/543	p.Y72*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Nonsense_Mutation	29/543	p.Q29*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Nonsense_Mutation	20/543	p.Q20*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CHEK2	Frame_Shift_Del	6/543	p.D6Mfs*55	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28779002;19401704;27464310;32343890								
CIC	Splice_Site	900/1608	p.X900_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22072542;24086756;22588899;21817013;24117486								
CIC	Frame_Shift_Ins	1114/1608	p.S1117Kfs*34	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22072542;24086756;22588899;21817013;24117486								
CIC	Nonsense_Mutation	1170/1608	p.Q1170*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22072542;24086756;22588899;21817013;24117486								
CIC	Splice_Site	1347/1608	p.X1347_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22072542;24086756;22588899;21817013;24117486								
CTCF	Splice_Site	567/727	p.X567_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23636398;25079317;24130125								
CYLD	Splice_Site	377/953	p.X377_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27775078;23426135								
DAXX	Nonsense_Mutation	286/740	p.Y286*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29092957;21252315								
DAXX	Frame_Shift_Ins	243-244/740	p.D244Rfs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29092957;21252315								
DICER1	Frame_Shift_Del	1658/1922	p.T1658Hfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20305640;22133720;22353998;21266384;21501861								
DICER1	Frame_Shift_Ins	1222/1922	p.L1222Ffs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20305640;22133720;22353998;21266384;21501861								
DICER1	Frame_Shift_Del	842/1922	p.M842Cfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20305640;22133720;22353998;21266384;21501861								
DICER1	Nonsense_Mutation	624/1922	p.R624*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20305640;22133720;22353998;21266384;21501861								
DICER1	Frame_Shift_Del	529/1922	p.P529Qfs*33	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20305640;22133720;22353998;21266384;21501861								
DICER1	Frame_Shift_Del	212/1922	p.K213Nfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20305640;22133720;22353998;21266384;21501861								
DICER1	Frame_Shift_Del	22-24/1922	p.P23Vfs*40	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20305640;22133720;22353998;21266384;21501861								
DNMT3A	Frame_Shift_Ins	392/912	p.S393Efs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24614070;21067377;25964253		MDS	AITL,ETPLL	LEVEL_Dx2				
DNMT3A	Nonsense_Mutation	320/912	p.R320*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24614070;21067377;25964253		MDS	AITL,ETPLL	LEVEL_Dx2				
DNMT3A	Frame_Shift_Ins	256-257/912	p.T257Hfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24614070;21067377;25964253		MDS	AITL,ETPLL	LEVEL_Dx2				
DNMT3B	Frame_Shift_Del	442/853	p.V444Cfs*146	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22133874								
DNMT3B	Frame_Shift_Del	486-493/853	p.L489Pfs*57	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22133874								
DNMT3B	Frame_Shift_Del	740/853	p.M742*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22133874								
ELF3	Frame_Shift_Ins	33/371	p.T34Hfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14976186;17148437;26806338								
ELF3	Nonsense_Mutation	124/371	p.Q124*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14976186;17148437;26806338								
ELF3	Nonsense_Mutation	126/371	p.R126*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14976186;17148437;26806338								
ELF3	Nonsense_Mutation	247/371	p.R247*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14976186;17148437;26806338								
ELF3	Splice_Site	334/371	p.X334_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14976186;17148437;26806338								
EPCAM	Frame_Shift_Del	29/314	p.C29*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23462293;21115857;23618806;24337010;25163760								
EPCAM	Frame_Shift_Del	36/314	p.N37Tfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23462293;21115857;23618806;24337010;25163760								
EPCAM	Nonsense_Mutation	50/314	p.S50*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23462293;21115857;23618806;24337010;25163760								
EPCAM	Splice_Site	62/314	p.X62_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23462293;21115857;23618806;24337010;25163760								
EPCAM	Nonsense_Mutation	76/314	p.S76*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23462293;21115857;23618806;24337010;25163760								
EPCAM	Nonsense_Mutation	109/314	p.Q109*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23462293;21115857;23618806;24337010;25163760								
EPCAM	Frame_Shift_Ins	110-111/314	p.N111Kfs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23462293;21115857;23618806;24337010;25163760								
EPCAM	Nonsense_Mutation	137/314	p.E137*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23462293;21115857;23618806;24337010;25163760								
EPCAM	Splice_Site	185/314	p.X185_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21145788								
EPCAM	Frame_Shift_Del	212/314	p.V212Wfs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21145788								
EPCAM	Frame_Shift_Del	234/314	p.T234Kfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21145788								
EPHA3	Splice_Site	324/983	p.X324_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15363810;22144690;25125683;28169277;18781894								
EPHA3	Splice_Site	477/983	p.X477_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15363810;22144690;25125683;28169277;18781894								
EPHA3	Splice_Site	783/983	p.X783_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15363810;22144690;25125683;28169277;18781894								
EPHA3	Nonsense_Mutation	790/983	p.W790*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15363810;22144690;25125683;28169277;18781894								
EPHA7	Nonsense_Mutation	895/998	p.R895*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										23676193;29022918;22036564;18821581;25968442;29223398								
EPHA7	Frame_Shift_Del	302/998	p.S302Lfs*46	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23676193;29022918;22036564;18821581;25968442;29223398								
ERBB2	Missense_Mutation	896/1255	p.R896C	SAMPLE			True	True	Gain-of-function	Oncogenic		Ado-Trastuzumab Emtansine,Trastuzumab Deruxtecan	Neratinib,Neratinib						LEVEL_2	29967253;23220880;31588020;29989854;30206164;Smit et al. Abstract# 9504, ASCO 2020(https://ascopubs.org/doi/10.1200/JCO.2020.38.15_suppl.9504);17311002;29420467								
ERBB4	Missense_Mutation	542/1308	p.E542K	SAMPLE			True	True	Gain-of-function	Oncogenic										29681454;19718025;28481359								
ERCC2	Nonsense_Mutation	698/760	p.Q698*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Missense_Mutation	683/760	p.R683Q	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	29980530;12208738;25096233;27310333								
ERCC2	Missense_Mutation	683/760	p.R683W	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	29980530;12208738;25096233;27310333								
ERCC2	Frame_Shift_Ins	669/760	p.K671Qfs*103	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Frame_Shift_Del	669/760	p.R669Gfs*104	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Frame_Shift_Del	669/760	p.R669Gfs*40	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Nonsense_Mutation	662/760	p.Q662*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Frame_Shift_Del	653/760	p.F654Sfs*55	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Splice_Site	635/760	p.X635_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Frame_Shift_Ins	623/760	p.V623Gfs*26	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Missense_Mutation	616/760	p.R616P	SAMPLE			True	False	Unknown																			
ERCC2	Frame_Shift_Del	603/760	p.K603Sfs*45	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Splice_Site	587/760	p.X587_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Splice_Site	586/760	p.X586_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Nonsense_Mutation	585/760	p.Q585*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Frame_Shift_Del	578-581/760	p.S578Wfs*128	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Frame_Shift_Ins	569-570/760	p.E570*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Frame_Shift_Del	568/760	p.F568Yfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Splice_Site	494/760	p.X494_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Splice_Site	459/760	p.X459_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Nonsense_Mutation	452/760	p.Q452*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Frame_Shift_Ins	395/760	p.S395Ffs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Nonsense_Mutation	339/760	p.Y339*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Frame_Shift_Del	333/760	p.L333*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Nonsense_Mutation	300/760	p.E300*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Splice_Site	272/760	p.X272_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Frame_Shift_Del	219-220/760	p.L220Gfs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Splice_Site	198/760	p.X198_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Frame_Shift_Del	197-198/760	p.Y197*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Nonsense_Mutation	189/760	p.W189*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Splice_Site	159/760	p.X159_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Nonsense_Mutation	156/760	p.R156*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Splice_Site	121/760	p.X121_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Nonsense_Mutation	88/760	p.R88*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Splice_Site	?-62/760	p.X62_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Splice_Site	?-48/760	p.X36_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC2	Splice_Site	36/760	p.X36_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Cisplatin						LEVEL_3A	27504877;12208738;25096233;29980530;27310333								
ERCC3	Nonsense_Mutation	645/782	p.R645*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Splice_Site	609/782	p.X609_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	591/782	p.Q591*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Frame_Shift_Ins	588/782	p.E588Gfs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Frame_Shift_Del	586/782	p.Q586Rfs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Frame_Shift_Ins	579/782	p.Y579Lfs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Frame_Shift_Del	579/782	p.Y579Ifs*32	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	574/782	p.R574*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	545/782	p.Q545*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	489/782	p.Y489*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Frame_Shift_Del	482/782	p.L483*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Frame_Shift_Ins	474/782	p.D474Efs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	452/782	p.R452*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Splice_Site	448/782	p.X448_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	434/782	p.E434*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	429/782	p.W429*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	425/782	p.R425*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	374/782	p.Q373_W374ins*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Frame_Shift_Del	341/782	p.C342Afs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	325/782	p.R325*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Frame_Shift_Del	270/782	p.F270*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Frame_Shift_Del	267-268/782	p.T267Cfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	254/782	p.Q254*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	234/782	p.R234*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Frame_Shift_Del	192-195/782	p.V193Rfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Splice_Site	157/782	p.X157_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC3	Nonsense_Mutation	109/782	p.R109*	SAMPLE			True	True	Loss-of-function	Likely Oncogenic										27655433								
ERCC3	Nonsense_Mutation	64/782	p.Q64*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16143348;27655433;8196650;19942596								
ERCC4	Nonsense_Mutation	5/916	p.Q5*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Nonsense_Mutation	46/916	p.Y46*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Frame_Shift_Del	77/916	p.K77Rfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Nonsense_Mutation	193/916	p.W193*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Frame_Shift_Del	261/916	p.F262Lfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Nonsense_Mutation	292/916	p.R292*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Splice_Site	368/916	p.X368_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Frame_Shift_Ins	399/916	p.A400Qfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Nonsense_Mutation	415/916	p.R415*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Nonsense_Mutation	459/916	p.S459*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Nonsense_Mutation	507/916	p.E507*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Frame_Shift_Del	627-628/916	p.E628Lfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Splice_Site	673/916	p.X673_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Missense_Mutation	689/916	p.R689S	SAMPLE			True	True	Loss-of-function	Oncogenic										23623386;24027083								
ERCC4	Nonsense_Mutation	723/916	p.C723*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Nonsense_Mutation	772/916	p.R772*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC4	Frame_Shift_Ins	781-782/916	p.N782Kfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8887684;9580660								
ERCC5	Frame_Shift_Del	17/1186	p.V17Afs*19	SAMPLE			True	False	Unknown																			
ERCC5	Nonsense_Mutation	138/1186	p.R138*	SAMPLE			True	False	Unknown																			
ERCC5	Nonsense_Mutation	176/1186	p.Q176*	SAMPLE			True	False	Unknown																			
ERCC5	Frame_Shift_Ins	196-197/1186	p.P197Sfs*3	SAMPLE			True	False	Unknown																			
ERCC5	Nonsense_Mutation	366/1186	p.R366*	SAMPLE			True	False	Unknown																			
ERCC5	Frame_Shift_Del	372-373/1186	p.R372Tfs*6	SAMPLE			True	False	Unknown																			
ERCC5	Frame_Shift_Ins	391/1186	p.K392*	SAMPLE			True	False	Unknown																			
ERCC5	Nonsense_Mutation	585/1186	p.E585*	SAMPLE			True	False	Unknown																			
ERCC5	Nonsense_Mutation	621/1186	p.Q621*	SAMPLE			True	False	Unknown																			
ERCC5	Frame_Shift_Ins	707/1186	p.D708Gfs*38	SAMPLE			True	False	Unknown																			
ERCC5	Frame_Shift_Ins	739/1186	p.E740Wfs*6	SAMPLE			True	False	Unknown																			
ERCC5	Nonsense_Mutation	753/1186	p.Q753*	SAMPLE			True	False	Unknown																			
ERCC5	Frame_Shift_Ins	900/1186	p.N902Kfs*7	SAMPLE			True	False	Unknown																			
ERCC5	Nonsense_Mutation	992/1186	p.R992*	SAMPLE			True	False	Unknown																			
ERCC5	Nonsense_Mutation	1002/1186	p.Q1002*	SAMPLE			True	False	Unknown																			
ERCC5	Frame_Shift_Del	1026-1027/1186	p.E1028Qfs*6	SAMPLE			True	False	Unknown																			
ERCC5	Nonsense_Mutation	1053/1186	p.G1053*	SAMPLE			True	False	Unknown																			
ERCC5	Frame_Shift_Del	1070-1072/1186	p.R1072Efs*6	SAMPLE			True	False	Unknown																			
ERCC5	Frame_Shift_Del	1071/1186	p.R1072Kfs*7	SAMPLE			True	False	Unknown																			
ERCC5	Nonsense_Mutation	1080/1186	p.G1080*	SAMPLE			True	False	Unknown																			
ERCC5	Frame_Shift_Del	1122/1186	p.T1124Pfs*10	SAMPLE			True	False	Unknown																			
ERRFI1	Nonsense_Mutation	400/462	p.R400*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16648858;17599051;26280531;21576352;11003669;22701735;16247031;11843178;16819504;18046415;25735773;12833145;20421427;24550739;15556944								
ERRFI1	Frame_Shift_Ins	359/462	p.S360Cfs*17	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16648858;17599051;26280531;21576352;11003669;22701735;16247031;11843178;16819504;18046415;25735773;12833145;20421427;24550739;15556944								
ERRFI1	Frame_Shift_Del	145/462	p.C146*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16648858;17599051;26280531;21576352;11003669;22701735;16247031;11843178;16819504;18046415;25735773;12833145;20421427;24550739;15556944								
ERRFI1	Nonsense_Mutation	24/462	p.R24*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16648858;17599051;26280531;21576352;11003669;22701735;16247031;11843178;16819504;18046415;25735773;12833145;20421427;24550739;15556944								
ERRFI1	Nonsense_Mutation	10/462	p.E10*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16648858;17599051;26280531;21576352;11003669;22701735;16247031;11843178;16819504;18046415;25735773;12833145;20421427;24550739;15556944								
EZH2	Nonsense_Mutation	3/751	p.Q3*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic		Tazemetostat							LEVEL_2	20601954;27926872;33035457		CMML,MDS	DLBCLNOS,ETPLL,FL	LEVEL_Dx2	MDS,PMF	ET		LEVEL_Px1
FAM175A	Frame_Shift_Ins	381-382/409	p.A382Sfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Frame_Shift_Ins	369/409	p.S370Ifs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Frame_Shift_Del	337/409	p.A338Lfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Frame_Shift_Ins	288-289/409	p.P289Sfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Splice_Site	266/409	p.X266_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Nonsense_Mutation	237/409	p.E237*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Frame_Shift_Del	217-218/409	p.E217Vfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Splice_Site	199/409	p.X199_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Nonsense_Mutation	193/409	p.R193*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Frame_Shift_Ins	186-187/409	p.M187Yfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Nonsense_Mutation	183-184/409	p.S183_G184ins*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Nonsense_Mutation	183/409	p.S183*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Nonsense_Mutation	148/409	p.R148*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Nonsense_Mutation	122/409	p.Q122*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM175A	Nonsense_Mutation	4/409	p.E4*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25066119								
FAM58A	Frame_Shift_Ins	17/246	p.G17Afs*39	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24218572;18297069								
FAM58A	Frame_Shift_Ins	16/246	p.A19Gfs*37	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24218572;18297069								
FANCA	Nonsense_Mutation	1377/1455	p.S1377*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Del	1375/1455	p.T1375Sfs*49	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	1312/1455	p.X1312_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Ins	1306-1307/1455	p.Q1307Sfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	1276/1455	p.X1276_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	In_Frame_Del	1263-1264/1455	p.F1263del	SAMPLE			True	False	Unknown																			
FANCA	Frame_Shift_Del	1232/1455	p.F1232Lfs*15	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	1224/1455	p.W1224*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Ins	1186-1187/1455	p.R1187Efs*28	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Missense_Mutation	1131/1455	p.T1131A	SAMPLE			True	False	Unknown																			
FANCA	Missense_Mutation	1117/1455	p.R1117G	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										22778927;11739169;29098742;10373536;9371798								
FANCA	Splice_Site	1116/1455	p.X1116_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	1063/1455	p.W1063*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	994/1455	p.X994_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Ins	972/1455	p.C973Lfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	951/1455	p.X951_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	947/1455	p.S947*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	927/1455	p.X927_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Del	910-911/1455	p.W911Dfs*31	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	866/1455	p.K866*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	852/1455	p.S852*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Del	845-846/1455	p.C846Qfs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	773/1455	p.X773_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Ins	724-725/1455	p.S725Vfs*69	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	676/1455	p.Q676*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Del	648/1455	p.E648Dfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	609/1455	p.X609_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	?-595/1455	p.X593_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	593/1455	p.X593_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	591/1455	p.R591*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	578-580/1455	p.Y578_V580delins*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	572/1455	p.X572_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	549/1455	p.Q549*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Del	539/1455	p.D539Tfs*66	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	522/1455	p.X522_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Del	473/1455	p.L473Cfs*53	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Del	372-373/1455	p.V372Afs*42	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	343/1455	p.Q343*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Del	306/1455	p.T306Afs*32	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	298/1455	p.X298_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	288/1455	p.E288*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Ins	284/1455	p.V285Sfs*54	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	264/1455	p.Q264*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	199/1455	p.X199_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	174/1455	p.X174_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	142/1455	p.X142_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Splice_Site	95/1455	p.X95_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	86/1455	p.Y86*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Nonsense_Mutation	22/1455	p.W22*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Ins	6/1455	p.V6Gfs*31	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Frame_Shift_Ins	4/1455	p.W5Vfs*32	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCA	Translation_Start_Site	1/1455	p.M1?	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12637330;11739169;21273304;12827451								
FANCC	Nonsense_Mutation	555/558	p.R555*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Nonsense_Mutation	543/558	p.S543*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Splice_Site	511/558	p.X511_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Nonsense_Mutation	424/558	p.W424*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Splice_Site	332/558	p.X332_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Frame_Shift_Del	312/558	p.I312Sfs*61	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Nonsense_Mutation	279/558	p.S279*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Frame_Shift_Ins	266-267/558	p.N267Efs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Frame_Shift_Del	191/558	p.I191Yfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Nonsense_Mutation	185/558	p.R185*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Splice_Site	174/558	p.X174_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Frame_Shift_Ins	152/558	p.N152Kfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Frame_Shift_Del	126/558	p.R126Ifs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Splice_Site	116/558	p.X116_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Frame_Shift_Ins	89/558	p.I89Nfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Frame_Shift_Del	23/558	p.D23Ifs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Nonsense_Mutation	22/558	p.W22*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Nonsense_Mutation	13/558	p.Q13*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FANCC	Frame_Shift_Del	3/558	p.Q3Rfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11520787;16687415;20509860								
FAT1	Frame_Shift_Del	4372/4588	p.Q4372Sfs*34	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Splice_Site	4334/4588	p.X4334_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Del	4292/4588	p.V4292Afs*27	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Del	3745/4588	p.W3745Gfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Ins	3526/4588	p.S3526Ffs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Del	3349/4588	p.E3351Sfs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Del	3333/4588	p.P3333Rfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Ins	3085/4588	p.L3085Pfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Del	2823/4588	p.G2825Efs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Del	2771/4588	p.T2771Ifs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Nonsense_Mutation	2726/4588	p.R2726*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Ins	2646/4588	p.L2646Ffs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Del	2422/4588	p.I2422Rfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Nonsense_Mutation	2350/4588	p.Y2350*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Del	2246-2251/4588	p.A2246Gfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Nonsense_Mutation	2167/4588	p.E2167*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Splice_Site	1441/4588	p.X1441_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Nonsense_Mutation	1303/4588	p.E1303*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Nonsense_Mutation	1070/4588	p.R1070*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Del	569-570/4588	p.F569Rfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Del	507/4588	p.H507Rfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Nonsense_Mutation	372/4588	p.Y372*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Nonsense_Mutation	132/4588	p.R132*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Nonsense_Mutation	26/4588	p.R26*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FAT1	Frame_Shift_Del	1/4588	p.M1?	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24718888;30537512;26905694;23354438								
FBXW7	Nonsense_Mutation	13/707	p.R13*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15103331;18094723;17646409		TLL		LEVEL_Dx2			TLL	LEVEL_Px3
FGFR2	Missense_Mutation	638/821	p.N638T	SAMPLE			True	False	Unknown																			
FGFR2	Missense_Mutation	253/821	p.P253R	SAMPLE	Y		True	True	Gain-of-function	Oncogenic					Debio1347,Infigratinib,Erdafitinib,AZD4547				LEVEL_4	18552176;24265351;11121055;26438159;31088831;25169980;27870574;23082000;31340094;30745300;Brichory F et al. Abstract# 2088, AACR 2017(http://cancerres.aacrjournals.org/content/77/13_Supplement/2088)								
FGFR3	Missense_Mutation	250/806	p.P250R	SAMPLE		Y	True	False	Unknown																			
FGFR3	Missense_Mutation	538/806	p.I538V	SAMPLE			True	True	Gain-of-function	Likely Oncogenic					Debio1347,Infigratinib,Erdafitinib,AZD4547				LEVEL_4	29736252;26992226;26438159;21119661;31088831;29848605;26324363;25169980;27870574;23082000;31340094;30745300;Siefker-Radtke et al. Abstract#4503, ASCO 2018(https://meetinglibrary.asco.org/record/160559/abstract);Brichory F et al. Abstract# 2088, AACR 2017(http://cancerres.aacrjournals.org/content/77/13_Supplement/2088)								
FH	Missense_Mutation	465/510	p.Y465C	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										12772087;21398687;16597677								
FH	Splice_Site	464/510	p.X464_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15937070;11865300;12772087;12761039								
FH	Missense_Mutation	419/510	p.S419P	SAMPLE			True	False	Unknown																			
FH	Frame_Shift_Del	403/510	p.F403Lfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15937070;11865300;12772087;12761039								
FH	Missense_Mutation	397/510	p.G397R	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										20618355;19183174;21398687								
FH	Frame_Shift_Del	361-362/510	p.E362Qfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15937070;11865300;12772087;12761039								
FH	Missense_Mutation	334/510	p.S334R	SAMPLE			True	False	Unknown																			
FH	Splice_Site	302/510	p.X302_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15937070;11865300;12772087;12761039								
FH	Missense_Mutation	195/510	p.M195T	SAMPLE			True	True	Inconclusive	Inconclusive										12772087;22764886								
FH	Splice_Site	186/510	p.X186_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15937070;11865300;12772087;12761039								
FH	Splice_Site	89/510	p.X89_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15937070;11865300;12772087;12761039								
FH	Frame_Shift_Ins	80/510	p.I81Dfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15937070;11865300;12772087;12761039								
FH	Nonsense_Mutation	71/510	p.Q71*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15937070;11865300;12772087;12761039								
FH	Nonsense_Mutation	43/510	p.R43*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15937070;11865300;12772087;12761039								
FLCN	Frame_Shift_Del	460/579	p.L460Qfs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Nonsense_Mutation	434/579	p.E434*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Frame_Shift_Ins	429/579	p.H429Pfs*27	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Frame_Shift_Del	429/579	p.H429Tfs*39	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Nonsense_Mutation	405/579	p.Y405*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Nonsense_Mutation	373/579	p.Q373*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Frame_Shift_Del	346-348/579	p.F346Pfs*41	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Frame_Shift_Del	329/579	p.S330Pfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Frame_Shift_Ins	318-319/579	p.G319Sfs*80	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Splice_Site	260/579	p.X260_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Splice_Site	206/579	p.X206_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Frame_Shift_Del	168-171/579	p.R168Hfs*28	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Frame_Shift_Ins	116/579	p.L117Afs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLCN	Splice_Site	84/579	p.X84_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27486260;28656962;23108783								
FLT3	Missense_Mutation	842/993	p.Y842C	SAMPLE			True	True	Likely Gain-of-function	Likely Oncogenic										27276561;15345593		AML	ETPLL	LEVEL_Dx2				
FOXA1	Nonsense_Mutation	425/472	p.Q425*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24840332;26544944								
FOXP1	Frame_Shift_Ins	641/677	p.D641Gfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25329375								
GPS2	Splice_Site	160/327	p.X160_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										30096302;19858209								
GPS2	Frame_Shift_Del	48-53/327	p.Q48Kfs*43	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										30096302;19858209								
GPS2	Frame_Shift_Del	42-43/327	p.K43Dfs*53	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										30096302;19858209								
HLA-A	Nonsense_Mutation	108/365	p.Y108*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15546342								
HLA-A	Nonsense_Mutation	125/365	p.C125*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15546342								
HLA-A	Nonsense_Mutation	142/365	p.Y142*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15546342								
HLA-A	Frame_Shift_Ins	187/365	p.E190Rfs*32	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15546342								
HLA-A	Frame_Shift_Del	199/365	p.K200Rfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15546342								
HLA-B	Nonstop_Mutation	363/362	p.*363Rext*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19845903;27807939;14675390;26889905;28205408								
HLA-B	Frame_Shift_Del	292/362	p.K292Nfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19845903;27807939;14675390;26889905;28205408								
HLA-B	Frame_Shift_Ins	209/362	p.T211Dfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19845903;27807939;14675390;26889905;28205408								
HNF1A	Missense_Mutation	276/631	p.A276G	SAMPLE			True	False	Unknown																			
HNF1A	Frame_Shift_Ins	288/631	p.P289Afs*28	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25793983;18003757;12574234								
HNF1A	Frame_Shift_Ins	288-289/631	p.G292Rfs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25793983;18003757;12574234								
HOXB13	Frame_Shift_Del	168/284	p.S168Vfs*111	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28798948;22236224;15928669;15126340								
HOXB13	Nonsense_Mutation	109/284	p.Y109*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28798948;22236224;15928669;15126340								
HOXB13	Missense_Mutation	84/284	p.G84E	SAMPLE			True	True	Inconclusive	Likely Oncogenic										26517352;23518396;29259341;24026887;32830201;23064873;22841674								
HOXB13	Frame_Shift_Del	50/284	p.L51Wfs*47	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28798948;22236224;15928669;15126340								
HOXB13	Frame_Shift_Ins	24-25/284	p.R25Afs*102	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28798948;22236224;15928669;15126340								
HOXB13	Frame_Shift_Del	3/284	p.P3Rfs*123	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28798948;22236224;15928669;15126340								
IDH2	Missense_Mutation	140/452	p.R140Q	SAMPLE	Y		True	True	Switch-of-function	Oncogenic	Enasidenib	Enasidenib							LEVEL_1	24440599;20692206;31932841;20847235;20171147;25043045;28588020;30967620		AML	AITL	LEVEL_Dx2		ET,PV,PMF		LEVEL_Px2
IFNGR1	Frame_Shift_Del	175/489	p.Y175Mfs*2	SAMPLE			True	False	Unknown																			
INPP4B	Nonsense_Mutation	142/924	p.R142*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25428846;19647222;21127264								
INPPL1	Nonsense_Mutation	17/1258	p.Q17*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23273567;23273569;30464521;27708270;19082482;19272022								
INPPL1	Splice_Site	364/1258	p.X364_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23273567;23273569;30464521;27708270;19082482;19272022								
INPPL1	Frame_Shift_Del	372/1258	p.R372Lfs*40	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23273567;23273569;30464521;27708270;19082482;19272022								
INPPL1	Nonsense_Mutation	626/1258	p.K626*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23273567;23273569;30464521;27708270;19082482;19272022								
INPPL1	Frame_Shift_Ins	886-887/1258	p.E887Wfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23273567;23273569;30464521;27708270;19082482;19272022								
INPPL1	Nonsense_Mutation	887/1258	p.E887*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23273567;23273569;30464521;27708270;19082482;19272022								
INPPL1	Splice_Site	887/1258	p.X887_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23273567;23273569;30464521;27708270;19082482;19272022								
INPPL1	Frame_Shift_Ins	974/1258	p.P977Tfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23273567;23273569;30464521;27708270;19082482;19272022								
INPPL1	Frame_Shift_Del	1031-1034/1258	p.H1031Rfs*97	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23273567;23273569;30464521;27708270;19082482;19272022								
INPPL1	Frame_Shift_Del	1095-1096/1258	p.P1095Afs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23273567;23273569;30464521;27708270;19082482;19272022								
INPPL1	Frame_Shift_Ins	1153-1154/1258	p.R1156Pfs*59	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23273567;23273569;30464521;27708270;19082482;19272022								
JAK1	Splice_Site	487/1154	p.X487_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29121062;24154688;12576323			ETPLL	LEVEL_Dx3				
JAK1	Nonsense_Mutation	459/1154	p.E459*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29121062;24154688;12576323			ETPLL	LEVEL_Dx3				
JAK1	Nonsense_Mutation	138/1154	p.Y138*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29121062;24154688;12576323			ETPLL	LEVEL_Dx3				
JAK3	Silent	589/1124	p.G589=	SAMPLE			True	False	Unknown																			
KDM5C	Frame_Shift_Del	863/1560	p.L863Cfs*72	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22138691;20133580;15586325;23356856;21725364;25712104;24166983;21544224;25111482;20054297;20181063								
KDM5C	Frame_Shift_Del	198/1560	p.Q199Sfs*35	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22138691;20133580;15586325;23356856;21725364;25712104;24166983;21544224;25111482;20054297;20181063								
KDM5C	Missense_Mutation	30/1560	p.Y30C	SAMPLE			True	False	Unknown																			
KDM6A	Splice_Site	1070/1401	p.X1070_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					Tazemetostat				LEVEL_4	24633898;28228601;31201358;25225064;19330029;24123378;29045832								
KEAP1	Nonsense_Mutation	459/624	p.R459*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										17020408;24322982;24142871								
KEAP1	Frame_Shift_Del	26-27/624	p.A27Rfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										17020408;24322982;24142871								
KEAP1	Nonsense_Mutation	15/624	p.R15*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										17020408;24322982;24142871								
KIT	Missense_Mutation	829/976	p.A829P	SAMPLE			True	True	Inconclusive	Resistance	Imatinib,Sunitinib,Regorafenib,Ripretinib	Sorafenib			Nilotinib,Pazopanib		Imatinib,Sunitinib		LEVEL_1	21642685;18980976;25239608;18955458;18623623;28196207;18955451;18235122;12181401;17046465;23177515;32511981;22270258;23140824;Kindler et al. Abstract# 10009, ASCO 2011(http://meetinglibrary.asco.org/content/80567-102);21456006;19467857;24356634;31085175								
KLF4	Nonsense_Mutation	98/479	p.E98*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23348505;24168184;20699379;31515251;17130451;31123420;29062163								
KLF4	Frame_Shift_Del	12/479	p.V12Sfs*40	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23348505;24168184;20699379;31515251;17130451;31123420;29062163								
KMT2A	Splice_Site	3612/3972	p.X3612_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25998713								
KMT2B	Splice_Site	820/2715	p.X820_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27839873;25998713;16540515;17429066								
KMT2B	Frame_Shift_Ins	1020/2715	p.R1021Pfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27839873;25998713;16540515;17429066								
KMT2C	Splice_Site	2481/4911	p.X2481_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										30108106;25537518;23259788;19433796								
KMT2C	Frame_Shift_Ins	822/4911	p.K822Rfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										30108106;25537518;23259788;19433796								
KMT2C	Frame_Shift_Ins	816-817/4911	p.I817Yfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										30108106;25537518;23259788;19433796								
KMT2C	Frame_Shift_Del	767/4911	p.E767Vfs*28	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										30108106;25537518;23259788;19433796								
KMT2C	Splice_Site	605/4911	p.X605_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										30108106;25537518;23259788;19433796								
KMT2D	Splice_Site	4751/5537	p.X4751_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24633898;24240169;26366712			DLBCLNOS,FL	LEVEL_Dx3				
KMT2D	Frame_Shift_Ins	3692/5537	p.A3693Gfs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24633898;24240169;26366712			DLBCLNOS,FL	LEVEL_Dx3				
KMT2D	Splice_Site	1730/5537	p.X1730_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24633898;24240169;26366712			DLBCLNOS,FL	LEVEL_Dx3				
LATS1	Nonsense_Mutation	1021/1130	p.Q1021*	SAMPLE			True	False	Loss-of-function	Likely Oncogenic										23230145;11850843;9988269								
LATS1	Frame_Shift_Del	985-987/1130	p.I986Tfs*15	SAMPLE			True	False	Loss-of-function	Likely Oncogenic										23230145;11850843;9988269								
LATS1	Frame_Shift_Del	326-327/1130	p.R327Tfs*9	SAMPLE			True	False	Loss-of-function	Likely Oncogenic										23230145;11850843;9988269								
LATS1	Nonsense_Mutation	147/1130	p.R147*	SAMPLE			True	False	Loss-of-function	Likely Oncogenic										23230145;11850843;9988269								
LATS1	Nonsense_Mutation	32/1130	p.Q32*	SAMPLE			True	False	Loss-of-function	Likely Oncogenic										23230145;11850843;9988269								
LATS2	Frame_Shift_Ins	40/1088	p.P41Tfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21245096								
MAP3K1	Nonsense_Mutation	10/1512	p.S10*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24135036;11971970;10373563;24003131;24386504;25899310;25613373								
MAP3K1	Nonsense_Mutation	208/1512	p.R208*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24135036;11971970;10373563;24003131;24386504;25899310;25613373								
MAP3K1	Splice_Site	562/1512	p.X562_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24135036;11971970;10373563;24003131;24386504;25899310;25613373								
MAP3K1	Frame_Shift_Del	756/1512	p.R757Afs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24135036;11971970;10373563;24003131;24386504;25899310;25613373								
MAX	Nonsense_Mutation	143/160	p.E143*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24362264								
MED12	Frame_Shift_Ins	2147/2177	p.Q2148Sfs*72	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23913526;25108465;24123922;24746821								
MEN1	Nonsense_Mutation	465/615	p.R465*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12746426;14992727;9241276;9766672;27076911;9510467;9361035;21627674;9103196								
MEN1	Splice_Site	456/615	p.X456_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12746426;14992727;9241276;9766672;27076911;9510467;9361035;21627674;9103196								
MEN1	Nonsense_Mutation	441/615	p.W441*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12746426;14992727;9241276;9766672;27076911;9510467;9361035;21627674;9103196								
MEN1	Missense_Mutation	225/615	p.W225R	SAMPLE			True	False	Unknown																			
MEN1	Frame_Shift_Del	215-216/615	p.T215Sfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12746426;14992727;9241276;9766672;27076911;9510467;9361035;21627674;9103196								
MEN1	Nonsense_Mutation	108/615	p.R108*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12746426;14992727;9241276;9766672;27076911;9510467;9361035;21627674;9103196								
MEN1	Translation_Start_Site	1/615	p.M1?	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12746426;14992727;9241276;9766672;27076911;9510467;9361035;21627674;9103196								
MGA	Frame_Shift_Del	49/3065	p.L50Wfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23039309								
MGA	Frame_Shift_Del	769/3065	p.P770Lfs*47	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23039309								
MGA	Frame_Shift_Ins	1061/3065	p.A1062Sfs*30	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23039309								
MGA	Frame_Shift_Del	1169/3065	p.P1169Qfs*15	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23039309								
MGA	Frame_Shift_Del	2899/3065	p.L2900Sfs*35	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23039309								
MLH1	Splice_Site	39/756	p.X39_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Missense_Mutation	67/756	p.G67R	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										21120944;18383312								
MLH1	Nonsense_Mutation	78/756	p.E78*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Missense_Mutation	82/756	p.T82I	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22736432;24362816								
MLH1	Frame_Shift_Ins	95-96/756	p.T96Dfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Nonsense_Mutation	100/756	p.R100*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Splice_Site	102/756	p.X102_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Splice_Site	197/756	p.X197_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Nonsense_Mutation	226/756	p.R226*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Splice_Site	264/756	p.X264_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Splice_Site	?-265/756	p.X264_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Missense_Mutation	265/756	p.R265C	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										18205192;19419416;11781295								
MLH1	Frame_Shift_Ins	287/756	p.P290Tfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Missense_Mutation	295/756	p.S295N	SAMPLE			True	False	Unknown																			
MLH1	Missense_Mutation	306/756	p.N306K	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										12011148;24333619								
MLH1	Frame_Shift_Del	318/756	p.H318Qfs*49	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Nonsense_Mutation	351/756	p.G351*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Nonsense_Mutation	445/756	p.Q445*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Splice_Site	470/756	p.X470_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Frame_Shift_Ins	528/756	p.H528Rfs*30	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Frame_Shift_Del	531/756	p.V531Wfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Splice_Region	577/756	p.S577=	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Splice_Site	577/756	p.X577_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	In_Frame_Del	615-616/756	p.K618del	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										17510385;17569143;21681552;21642682;12891553;10422993								
MLH1	Missense_Mutation	640/756	p.P640S	SAMPLE			True	False	Unknown																			
MLH1	Missense_Mutation	648/756	p.P648S	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										16724012;23435383;24362816								
MLH1	Splice_Site	664/756	p.X664_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Missense_Mutation	681/756	p.A681T	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										18033691;28449805;23354017;17510385;27629256;12362047;22736432;23403630;8880570;16083711;15864295;28874130;21404117;21642682;25477341								
MLH1	Frame_Shift_Del	681-682/756	p.M682Vfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Frame_Shift_Ins	690-691/756	p.I691Lfs*93	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Nonsense_Mutation	694/756	p.E694*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Nonsense_Mutation	700/756	p.Q700*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Splice_Site	701/756	p.X701_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Frame_Shift_Del	713-717/756	p.K713Tfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Frame_Shift_Ins	731-732/756	p.H733Qfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Nonsense_Mutation	732/756	p.K732*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MLH1	Frame_Shift_Del	751/756	p.K751Sfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10359802;17086208;24362816;16216036;16623753;15713769;7892206;11781295								
MRE11A	Splice_Site	665/708	p.X665_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Frame_Shift_Ins	660/708	p.K661Tfs*45	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Splice_Site	643/708	p.X643_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Nonsense_Mutation	641/708	p.S641*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Nonsense_Mutation	633/708	p.R633*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Splice_Site	623/708	p.X623_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Nonsense_Mutation	576/708	p.R576*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Nonsense_Mutation	572/708	p.R572*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Nonsense_Mutation	506/708	p.E506*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Frame_Shift_Del	482/708	p.Q482Afs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Frame_Shift_Ins	408/708	p.T408Nfs*49	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Nonsense_Mutation	364/708	p.R364*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Splice_Site	339/708	p.X339_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Nonsense_Mutation	339/708	p.K339*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Frame_Shift_Ins	308/708	p.M309Hfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Splice_Site	220/708	p.X220_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Nonsense_Mutation	218/708	p.Q218*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Splice_Site	105/708	p.X105_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MRE11A	Frame_Shift_Del	19/708	p.T19Kfs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23912341;9705271;24927325;14684699;9590181;11741547;9651580								
MSH2	Frame_Shift_Del	76/934	p.S77Cfs*4	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	In_Frame_Del	99-101/934	p.E101_V102del	SAMPLE			True	False	Unknown																			
MSH2	Frame_Shift_Del	116-118/934	p.Y118Hfs*54	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Frame_Shift_Del	117/934	p.W117Cfs*57	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Missense_Mutation	162/934	p.G162R	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										28874130;17101317;24362816;18951462								
MSH2	Frame_Shift_Del	175/934	p.C176*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Nonsense_Mutation	177/934	p.E177*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Frame_Shift_Del	188/934	p.E188Gfs*26	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Frame_Shift_Del	196/934	p.K197Rfs*17	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Splice_Site	314/934	p.X314_splice	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Splice_Site	315/934	p.X315_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Frame_Shift_Del	324/934	p.Q324Vfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Missense_Mutation	333/934	p.C333Y	SAMPLE			True	False	Unknown																			
MSH2	Frame_Shift_Del	348/934	p.Q348Sfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Missense_Mutation	349/934	p.P349R	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										21239990;26300997;24362816;24278394								
MSH2	Frame_Shift_Del	365/934	p.F366Lfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Nonsense_Mutation	383/934	p.R383*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Nonsense_Mutation	389/934	p.R389*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Nonsense_Mutation	406/934	p.R406*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Frame_Shift_Del	409-410/934	p.G410Yfs*6	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Nonsense_Mutation	419/934	p.Q419*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Frame_Shift_Del	434/934	p.V435Ffs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Frame_Shift_Del	517/934	p.Q518Vfs*10	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Nonsense_Mutation	521/934	p.Y521*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Frame_Shift_Del	568-569/934	p.E569Ifs*2	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Frame_Shift_Del	599-601/934	p.Q601Rfs*41	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Missense_Mutation	624/934	p.I624S	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										18822302								
MSH2	Missense_Mutation	636/934	p.A636P	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										10528862;12595050								
MSH2	Missense_Mutation	639/934	p.H639Y	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										9718327;16395668;24100870;24362816;11920458;8062247								
MSH2	Nonsense_Mutation	656/934	p.Y656*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Splice_Site	669/934	p.X669_splice	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Nonsense_Mutation	680/934	p.R680*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Missense_Mutation	683/934	p.G683R	SAMPLE			True	False	Unknown																			
MSH2	Missense_Mutation	694/934	p.F694S	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										27629256;21156417								
MSH2	Missense_Mutation	697/934	p.C697R	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										21239990;17973265;14970868;12377806;10612836;10471663;17720936								
MSH2	Frame_Shift_Ins	712/934	p.G713Rfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Frame_Shift_Ins	723/934	p.T724Hfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Frame_Shift_Del	783/934	p.H783Lfs*29	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Splice_Site	820/934	p.X820_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Nonsense_Mutation	822/934	p.C822*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH2	Nonsense_Mutation	879/934	p.Q879*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										8592341;11257106;23391514;15528792;24362816;10946232;7726159;8566964								
MSH3	Frame_Shift_Del	87-88/1137	p.K88Tfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Splice_Site	120/1137	p.X120_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Frame_Shift_Del	171/1137	p.D171Efs*62	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Nonsense_Mutation	189/1137	p.Q189*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Splice_Site	193/1137	p.X193_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Nonsense_Mutation	214/1137	p.Q214*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Nonsense_Mutation	235/1137	p.Q235*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Nonsense_Mutation	241/1137	p.Q241*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Nonsense_Mutation	268/1137	p.R268*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Frame_Shift_Del	326-328/1137	p.F326Lfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Splice_Site	343/1137	p.X343_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Frame_Shift_Ins	353-354/1137	p.V354Gfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Frame_Shift_Del	436-437/1137	p.E437Gfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Splice_Site	447/1137	p.X447_splice	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Frame_Shift_Ins	541-542/1137	p.L542Ffs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Frame_Shift_Del	756-757/1137	p.K757Tfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Splice_Site	812/1137	p.X812_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Splice_Site	885/1137	p.X885_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Nonsense_Mutation	896/1137	p.G896*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Frame_Shift_Del	899/1137	p.M899Gfs*48	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Frame_Shift_Del	935/1137	p.I935Ffs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Nonsense_Mutation	949/1137	p.Q949*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Frame_Shift_Ins	979/1137	p.T981Rfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH3	Splice_Site	1001/1137	p.X1001_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28528517;10706084;27476653								
MSH6	Frame_Shift_Del	37/1360	p.A40Pfs*41	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Ins	78/1360	p.T86Ifs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Ins	217/1360	p.K218*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	414/1360	p.W414*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	417/1360	p.K417Sfs*36	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	482/1360	p.R482*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	486-487/1360	p.E487Dfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	495/1360	p.R495*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	523-524/1360	p.Y524Qfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	584/1360	p.L585Sfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	602/1360	p.S602*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	645/1360	p.K646Sfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	686/1360	p.G686Vfs*50	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Ins	687/1360	p.C687Sfs*53	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	732/1360	p.R732*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	740/1360	p.L740*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Ins	743/1360	p.E744Gfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Ins	765/1360	p.C765Wfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	873/1360	p.I874Sfs*32	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	911/1360	p.R911*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	954/1360	p.Y954*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	1035/1360	p.R1035*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	1079-1080/1360	p.L1080Vfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Ins	1085/1360	p.F1088Lfs*5	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										21674763;15837969								
MSH6	Frame_Shift_Del	1085/1360	p.F1088Sfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	1090/1360	p.E1090*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	1155/1360	p.Q1155*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	1159/1360	p.Y1159Rfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	1159/1360	p.Y1159*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	1187/1360	p.S1188Vfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Ins	1189-1190/1360	p.V1192Cfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	1233-1234/1360	p.K1233Nfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Ins	1248/1360	p.Y1249Lfs*26	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Ins	1264-1265/1360	p.H1266Tfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	1280-1282/1360	p.E1281Lfs*44	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Ins	1311/1360	p.I1313Sfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	1319-1320/1360	p.A1320Efs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Del	1323-1326/1360	p.K1325Sfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Frame_Shift_Ins	1327/1360	p.L1330Vfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Nonsense_Mutation	1331/1360	p.R1331*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24755471;9822680;24362816;22810696;9111312;1651234;9564049								
MSH6	Missense_Mutation	1334/1360	p.R1334Q	SAMPLE			True	False	Unknown																			
MST1	Nonsense_Mutation	607/725	p.W607*	SAMPLE			True	False	Unknown																			
MST1	Nonsense_Mutation	567/725	p.Q567*	SAMPLE			True	False	Unknown																			
MST1	Nonsense_Mutation	560/725	p.Q560*	SAMPLE			True	False	Unknown																			
MST1	Frame_Shift_Del	547-550/725	p.G547Yfs*22	SAMPLE			True	False	Unknown																			
MST1	Nonsense_Mutation	530/725	p.W530*	SAMPLE			True	False	Unknown																			
MST1	Frame_Shift_Ins	474/725	p.D475Qfs*52	SAMPLE			True	False	Unknown																			
MST1	Nonsense_Mutation	460/725	p.R460*	SAMPLE			True	False	Unknown																			
MST1	Frame_Shift_Del	49-50/725	p.Q49Pfs*18	SAMPLE			True	False	Unknown																			
MST1	Frame_Shift_Del	42/725	p.V42Afs*26	SAMPLE			True	False	Unknown																			
MST1	Frame_Shift_Ins	24-25/725	p.T25Dfs*15	SAMPLE			True	False	Unknown																			
MST1	Frame_Shift_Del	21/725	p.L21Cfs*4	SAMPLE			True	False	Unknown																			
MUTYH	Missense_Mutation	479/535	p.V479F	SAMPLE			True	False	Unknown																			
MUTYH	Splice_Site	478-?/535	p.X478_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Frame_Shift_Del	473/535	p.T474Pfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	In_Frame_Del	465-466/535	p.E466del	SAMPLE			True	False	Unknown																			
MUTYH	Nonsense_Mutation	465/535	p.E465*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Frame_Shift_Del	438/535	p.Y439Ifs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Nonsense_Mutation	400/535	p.Q400*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Frame_Shift_Ins	396/535	p.E396Gfs*43	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Missense_Mutation	391/535	p.P391L	SAMPLE			True	False	Unknown																			
MUTYH	Missense_Mutation	382/535	p.G382D	SAMPLE			True	False	Unknown																			
MUTYH	Frame_Shift_Del	372/535	p.Q372Kfs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Frame_Shift_Del	369/535	p.A371Pfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Nonsense_Mutation	324/535	p.Q324*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Missense_Mutation	281/535	p.P281L	SAMPLE			True	False	Unknown																			
MUTYH	Nonsense_Mutation	279/535	p.Q279*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Missense_Mutation	272/535	p.G272E	SAMPLE			True	False	Unknown																			
MUTYH	Nonsense_Mutation	253/535	p.Q253*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Frame_Shift_Del	250/535	p.G250Vfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Nonsense_Mutation	233/535	p.R233*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Missense_Mutation	231/535	p.R231H	SAMPLE			True	False	Unknown																			
MUTYH	Missense_Mutation	231/535	p.R231C	SAMPLE			True	False	Unknown																			
MUTYH	Missense_Mutation	227/535	p.R227Q	SAMPLE			True	False	Unknown																			
MUTYH	Missense_Mutation	227/535	p.R227W	SAMPLE			True	False	Unknown																			
MUTYH	Missense_Mutation	224/535	p.N224S	SAMPLE			True	False	Unknown																			
MUTYH	Splice_Site	179/535	p.X179_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Missense_Mutation	168/535	p.R168C	SAMPLE			True	False	Unknown																			
MUTYH	Missense_Mutation	165/535	p.Y165C	SAMPLE			True	False	Unknown																			
MUTYH	Splice_Site	155/535	p.X155_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Nonsense_Mutation	142/535	p.W142*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Nonsense_Mutation	141/535	p.K141*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Splice_Site	116/535	p.X116_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Missense_Mutation	95/535	p.R95W	SAMPLE			True	False	Unknown																			
MUTYH	Nonsense_Mutation	90/535	p.Y90*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Nonsense_Mutation	89/535	p.W89*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Nonsense_Mutation	83/535	p.R83*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Frame_Shift_Del	67-72/535	p.V67Ifs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Nonsense_Mutation	57/535	p.Q57*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Frame_Shift_Del	55/535	p.R56Gfs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
MUTYH	Nonsense_Mutation	29/535	p.Q29*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19032956;24834277;26109431								
NBN	Nonsense_Mutation	714/754	p.R714*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Ins	667-668/754	p.T668Yfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Del	662/754	p.L662Rfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Nonsense_Mutation	635/754	p.K635*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Nonsense_Mutation	632/754	p.W632*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Nonsense_Mutation	581/754	p.Q581*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Ins	552/754	p.E552Gfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Ins	551/754	p.R551Kfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Nonsense_Mutation	418/754	p.S418*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Del	389-392/754	p.M389Nfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Nonsense_Mutation	383/754	p.E383*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Del	381/754	p.P381Qfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Nonsense_Mutation	371/754	p.Q371*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Splice_Site	332/754	p.X332_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Ins	291/754	p.S292Vfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Del	279/754	p.Q279Rfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Ins	265/754	p.P266Sfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Del	233-234/754	p.K233Sfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Del	219-221/754	p.K219Nfs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Splice_Site	161/754	p.X161_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Nonsense_Mutation	128/754	p.L128*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Splice_Site	107/754	p.X107_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Splice_Site	58/754	p.X58_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Del	35-45/754	p.I35Mfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Nonsense_Mutation	43/754	p.R43*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Del	31-32/754	p.A32Hfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Del	20/754	p.G21Afs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Del	19/754	p.L19*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Splice_Site	13/754	p.X13_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Frame_Shift_Del	4/754	p.L4Rfs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NBN	Translation_Start_Site	1/754	p.M1?	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9590180								
NCOR1	Nonsense_Mutation	1229/2440	p.R1229*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21102521;7566114								
NCOR1	Splice_Site	1134/2440	p.X1134_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21102521;7566114								
NCOR1	Nonsense_Mutation	974/2440	p.E974*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21102521;7566114								
NCOR1	Frame_Shift_Del	535/2440	p.E535Kfs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21102521;7566114								
NF1	Splice_Site	68/2839	p.X68_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Splice_Site	97/2839	p.X97_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	162/2839	p.Q162*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Del	165-166/2839	p.C167Qfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	304/2839	p.R304*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Splice_Site	420/2839	p.X420_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	434/2839	p.C434*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	440/2839	p.R440*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	461/2839	p.R461*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	543/2839	p.Q543*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Del	585-586/2839	p.T586Vfs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Missense_Mutation	629/2839	p.G629R	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	24789688;12807981;26056819;26962827;18546366;23913538;28029918;32187457;31151904;24576830;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Ins	676/2839	p.I679Dfs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Ins	1077/2839	p.S1078Ffs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Del	1152-1153/2839	p.L1153Mfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Del	1210-1212/2839	p.L1211Qfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Del	1246-1247/2839	p.F1247Ifs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	1276/2839	p.R1276*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Splice_Site	1325/2839	p.X1325_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	1355/2839	p.S1355*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Ins	1357/2839	p.Q1360Sfs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	1360/2839	p.Q1360*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	1362/2839	p.R1362*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	1369/2839	p.Y1369*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Missense_Mutation	1447/2839	p.Q1447R	SAMPLE			True	False	Unknown																			
NF1	Frame_Shift_Del	1463/2839	p.P1463Lfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	1534/2839	p.R1534*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Splice_Site	1612/2839	p.X1612_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Del	1682/2839	p.C1682*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	1769/2839	p.R1769*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Missense_Mutation	1870/2839	p.R1870Q	SAMPLE	Y		True	False	Unknown	Predicted Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	28029918;32187457;31151904;24576830;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Splice_Site	2215/2839	p.X2215_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Del	2277/2839	p.C2278Afs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	2285/2839	p.Y2285*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Del	2345-2346/2839	p.D2346Vfs*49	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Del	2418/2839	p.L2419Gfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	2450/2839	p.R2450*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Ins	2636/2839	p.R2637Tfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Nonsense_Mutation	2637/2839	p.R2637*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF1	Frame_Shift_Del	2694/2839	p.P2695Hfs*44	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Selumetinib				Trametinib,Cobimetinib				LEVEL_1	31548343;8052307;19573811;26345759;8563751;23913538;7542586;7655472;24576830;10862084;23047742;10543400;12509763;14722914;31591187;28029918;32187457;31151904;26936308;24535670;Romo et al. Abstract# e13562, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e13562)		CMML,JMML		LEVEL_Dx2				
NF2	Frame_Shift_Ins	156-157/595	p.G161Sfs*45	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8755919;19545378;22825583;9643284								
NF2	Frame_Shift_Ins	538/595	p.L539Afs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8755919;19545378;22825583;9643284								
NKX3-1	Nonsense_Mutation	220/234	p.Y220*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16697957;18757402;11085535;11839815;22910912								
NKX3-1	Nonsense_Mutation	40/234	p.Q40*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										16697957;18757402;11085535;11839815;22910912								
NOTCH1	Missense_Mutation	365/2555	p.R365C	SAMPLE	Y		True	True	Unknown	Predicted Oncogenic												T-Lymphoblastic Leukemia/Lymphoma	CLLSLL	LEVEL_Dx2			T-Lymphoblastic Leukemia/Lymphoma	LEVEL_Px3
NOTCH1	Splice_Site	289/2555	p.X289_splice	SAMPLE			True	False	Likely Loss-of-function	Oncogenic										22006338;21948802;30770351;30087145;Devenport et al. Abstract # 1850. AACR, 2017(http://cancerres.aacrjournals.org/content/77/13_Supplement/1850)		T-Lymphoblastic Leukemia/Lymphoma	CLLSLL	LEVEL_Dx2			T-Lymphoblastic Leukemia/Lymphoma	LEVEL_Px3
NOTCH2	Nonsense_Mutation	1838/2471	p.R1838*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338			SMZL	LEVEL_Dx3				
NOTCH2	Nonsense_Mutation	755/2471	p.E755*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338			SMZL	LEVEL_Dx3				
NOTCH3	Frame_Shift_Ins	1976/2321	p.L1976Pfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Nonsense_Mutation	1670/2321	p.E1670*	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Splice_Site	1579/2321	p.X1579_splice	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Frame_Shift_Ins	1519-1520/2321	p.P1520Afs*43	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Frame_Shift_Del	1492-1494/2321	p.E1492Dfs*84	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Frame_Shift_Ins	1483/2321	p.C1484Pfs*85	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Frame_Shift_Ins	1481/2321	p.D1481Gfs*86	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Nonsense_Mutation	1458/2321	p.C1458*	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Frame_Shift_Del	1083/2321	p.Q1083Rfs*189	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Frame_Shift_Del	1026/2321	p.P1026Lfs*246	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Nonsense_Mutation	968/2321	p.S968*	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Splice_Site	931/2321	p.X931_splice	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Nonsense_Mutation	806/2321	p.R806*	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Frame_Shift_Del	797-798/2321	p.C798Pfs*54	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Frame_Shift_Ins	728/2321	p.R728Pfs*12	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Frame_Shift_Del	719/2321	p.C720Vfs*140	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Nonsense_Mutation	313/2321	p.Q313*	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH3	Frame_Shift_Del	42/2321	p.P42Lfs*194	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic										25870235;25394726								
NOTCH4	Nonsense_Mutation	1894/2003	p.Y1894*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	1886/2003	p.L1886*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Del	1788-1797/2003	p.L1789Pfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Splice_Site	1767/2003	p.X1767_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Del	1749/2003	p.A1749Pfs*34	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Del	1709-1712/2003	p.A1709Gfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	1643/2003	p.R1643*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Del	1638/2003	p.L1638Rfs*68	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	1616/2003	p.W1616*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	1612/2003	p.C1612*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Splice_Site	1586/2003	p.X1586_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	1571/2003	p.Q1571*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	1489/2003	p.R1489*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Splice_Site	1439/2003	p.X1439_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Del	1429/2003	p.L1429Rfs*29	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Ins	1306/2003	p.A1307Sfs*28	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Splice_Site	1252/2003	p.X1252_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	1232/2003	p.Q1232*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Ins	1219/2003	p.R1219Pfs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Del	1168-1169/2003	p.R1169Vfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	1158/2003	p.R1158*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	1125/2003	p.C1125*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Del	1049-1054/2003	p.C1050Afs*72	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Splice_Site	1040/2003	p.X1040_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Splice_Site	955/2003	p.X955_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Ins	921/2003	p.F922Ifs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Ins	920/2003	p.G921Wfs*15	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Del	920/2003	p.P920Lfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Splice_Site	894/2003	p.X894_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Ins	865-866/2003	p.F866Lfs*70	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Del	622-623/2003	p.Q622Hfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	601/2003	p.G601*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	576/2003	p.K576*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	569/2003	p.Q569*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Frame_Shift_Ins	319/2003	p.E319Gfs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	187/2003	p.E187*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Splice_Site	151/2003	p.X151_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	149/2003	p.W149*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NOTCH4	Nonsense_Mutation	136/2003	p.Q136*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22006338;21948802;15187023;31483290								
NSD1	Nonsense_Mutation	49/2696	p.Q49*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20018718;29176703								
NSD1	Nonsense_Mutation	2313/2696	p.Q2313*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20018718;29176703								
NSD1	Nonsense_Mutation	2373/2696	p.Q2373*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20018718;29176703								
NTHL1	Nonsense_Mutation	287/312	p.Q287*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25938944;30753826								
NTHL1	Frame_Shift_Del	273/312	p.E273Dfs*68	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25938944;30753826								
NTHL1	Nonsense_Mutation	269/312	p.W269*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25938944;30753826								
NTHL1	Nonsense_Mutation	210/312	p.E210*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25938944;30753826								
NTHL1	Frame_Shift_Del	162/312	p.D162Tfs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25938944;30753826								
NTHL1	Frame_Shift_Ins	125/312	p.V127Gfs*43	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25938944;30753826								
NTHL1	Nonsense_Mutation	90/312	p.Q90*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25938944;30753826								
NTHL1	Splice_Site	47/312	p.X47_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25938944;30753826								
PALB2	Nonsense_Mutation	1183/1186	p.Y1183*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	1169-1170/1186	p.H1170Ffs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	1142-1143/1186	p.L1142Ffs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	1121/1186	p.G1121Vfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	1108/1186	p.Y1108Sfs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	1086/1186	p.R1086*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	1078/1186	p.C1078*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	1039/1186	p.N1039Ifs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	1038/1186	p.W1038*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Splice_Site	999/1186	p.X999_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Ins	992/1186	p.M992Ifs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	990/1186	p.E990*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	988/1186	p.V989*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Ins	977-978/1186	p.V978Sfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	909-910/1186	p.T911Lfs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Ins	882/1186	p.C882Wfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	859/1186	p.S859*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	830/1186	p.E830Sfs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Ins	826/1186	p.N826Kfs*26	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	804/1186	p.S804Cfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	803/1186	p.S804Lfs*47	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Ins	773/1186	p.T773Nfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	723/1186	p.M723Vfs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	707/1186	p.P707Lfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	684/1186	p.R686Gfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	559/1186	p.V560*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	524/1186	p.S524*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	493/1186	p.T494Lfs*67	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	484/1186	p.L484*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	430/1186	p.Q430*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	414/1186	p.R414*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	380-381/1186	p.S380Rfs*43	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	350-351/1186	p.T351Rfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	314/1186	p.Q314*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Ins	274/1186	p.T274Nfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	253/1186	p.L253Ifs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Ins	236/1186	p.L237Pfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	232/1186	p.G232Vfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	190/1186	p.S190*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Ins	180/1186	p.E181Ffs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	180/1186	p.E180*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Nonsense_Mutation	179/1186	p.Q179*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	170/1186	p.R170Ifs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Ins	168/1186	p.S168Ffs*17	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	163/1186	p.V163Lfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	76/1186	p.I76Yfs*101	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Del	58-59/1186	p.Q60Rfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Frame_Shift_Ins	31-32/1186	p.L32Tfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PALB2	Splice_Site	17/1186	p.X17_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	28279176;29484706;25529982;28779002;28858227;18053174;32343890								
PARK2	Frame_Shift_Del	349/465	p.K349Sfs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31409571;28306514;27593930;29995846;29209642								
PARK2	Nonsense_Mutation	268/465	p.C268*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31409571;28306514;27593930;29995846;29209642								
PARK2	Splice_Site	245/465	p.X245_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31409571;28306514;27593930;29995846;29209642								
PARK2	Frame_Shift_Del	113-126/465	p.P113Tfs*51	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31409571;28306514;27593930;29995846;29209642								
PARK2	Frame_Shift_Del	117/465	p.V117Gfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31409571;28306514;27593930;29995846;29209642								
PARK2	Nonsense_Mutation	79/465	p.E79*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31409571;28306514;27593930;29995846;29209642								
PARK2	Frame_Shift_Del	52/465	p.N52Mfs*29	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31409571;28306514;27593930;29995846;29209642								
PARK2	Frame_Shift_Del	34/465	p.Q34Rfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31409571;28306514;27593930;29995846;29209642								
PARK2	Nonsense_Mutation	25/465	p.Q25*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31409571;28306514;27593930;29995846;29209642								
PARK2	Splice_Site	3/465	p.X3_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31409571;28306514;27593930;29995846;29209642								
PARP1	Frame_Shift_Ins	841/1014	p.E842Mfs*39	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9285557;24916104								
PARP1	Frame_Shift_Del	830-833/1014	p.D830Efs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9285557;24916104								
PARP1	Splice_Site	690/1014	p.X690_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9285557;24916104								
PARP1	Nonsense_Mutation	576/1014	p.E576*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9285557;24916104								
PARP1	Nonsense_Mutation	452/1014	p.R452*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9285557;24916104								
PARP1	Frame_Shift_Ins	408/1014	p.K409Efs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9285557;24916104								
PARP1	Splice_Site	239/1014	p.X239_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9285557;24916104								
PARP1	Frame_Shift_Del	213/1014	p.V213Gfs*26	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										9285557;24916104								
PAX5	Splice_Site	159/391	p.X159_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25855603;17344859								
PBRM1	Frame_Shift_Del	378/1582	p.F379Lfs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21248752;18339845;24613357;22949125;21654818;31486842								
PBRM1	Splice_Site	300/1582	p.X300_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21248752;18339845;24613357;22949125;21654818;31486842								
PHOX2B	Frame_Shift_Del	78-80/314	p.Y78*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										15888479;27129232;23873030;18079495;15338462								
PIK3R1	Frame_Shift_Del	70/724	p.G71Efs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25284480;25133428;25488983								
PIK3R1	Splice_Site	523/724	p.X523_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25284480;25133428;25488983								
PIK3R2	Frame_Shift_Del	83-85/728	p.G87Sfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23810382								
PIK3R2	Splice_Site	301/728	p.X301_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23810382								
PIK3R2	Nonsense_Mutation	332/728	p.W332*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23810382								
PIK3R2	Splice_Site	370/728	p.X370_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23810382								
PIK3R2	Frame_Shift_Del	498/728	p.Q498Rfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23810382								
PIK3R2	Frame_Shift_Del	590-591/728	p.I591Tfs*45	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23810382								
PIK3R2	Nonsense_Mutation	648/728	p.E648*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23810382								
PIK3R2	Nonsense_Mutation	686/728	p.Y686*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23810382								
PIK3R3	Frame_Shift_Del	397/461	p.D398Mfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Nonsense_Mutation	389/461	p.G389*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Frame_Shift_Ins	358/461	p.W358Cfs*32	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Frame_Shift_Ins	350/461	p.P351Afs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Nonsense_Mutation	309/461	p.R309*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Nonsense_Mutation	306/461	p.R306*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Nonsense_Mutation	289/461	p.R289*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Nonsense_Mutation	286/461	p.L286*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Frame_Shift_Del	275/461	p.M275Cfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Splice_Site	255/461	p.X255_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Nonsense_Mutation	255/461	p.R255*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Nonsense_Mutation	243/461	p.R243*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Frame_Shift_Del	223-224/461	p.I223Kfs*34	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Nonsense_Mutation	221/461	p.E221*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Frame_Shift_Ins	140-141/461	p.H141Sfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Frame_Shift_Ins	118/461	p.R118Pfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Nonsense_Mutation	90/461	p.R90*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Nonsense_Mutation	66/461	p.Y66*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PIK3R3	Nonsense_Mutation	65/461	p.W65*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27766312;25424831								
PMAIP1	Frame_Shift_Ins	10/54	p.Q11Sfs*77	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24457957;14500711;19641509;24387758								
PMS1	Nonsense_Mutation	10/932	p.R10*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Splice_Site	45/932	p.X45_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Nonsense_Mutation	55/932	p.R55*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Frame_Shift_Del	79/932	p.N79Kfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Nonsense_Mutation	90/932	p.Y90*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Nonsense_Mutation	120/932	p.Q120*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Frame_Shift_Del	148-149/932	p.L148*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Frame_Shift_Ins	162/932	p.C165Mfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Nonsense_Mutation	233/932	p.Q233*	SAMPLE			True	True	Loss-of-function	Likely Oncogenic										8072530								
PMS1	Nonsense_Mutation	265/932	p.R265*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Nonsense_Mutation	277/932	p.R277*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Nonsense_Mutation	450/932	p.Q450*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Frame_Shift_Ins	459/932	p.S460Kfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Frame_Shift_Del	508/932	p.V508Gfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Nonsense_Mutation	569/932	p.R569*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Nonsense_Mutation	609/932	p.W609*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Nonsense_Mutation	630/932	p.R630*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Nonsense_Mutation	643/932	p.S643*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Frame_Shift_Del	649-650/932	p.D649Efs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Frame_Shift_Del	742/932	p.E743Rfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS1	Frame_Shift_Del	863/932	p.E864Kfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28687356;8072530								
PMS2	Frame_Shift_Ins	657/862	p.N657Kfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Nonsense_Mutation	643/862	p.Q643*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Frame_Shift_Ins	611-612/862	p.N612*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Frame_Shift_Ins	611/862	p.I611Nfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Nonsense_Mutation	563/862	p.R563*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Frame_Shift_Ins	500-501/862	p.V501Rfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Nonsense_Mutation	375/862	p.Q375*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Frame_Shift_Ins	359/862	p.L359Ffs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Frame_Shift_Del	351/862	p.L351Ffs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Splice_Site	330/862	p.X330_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Nonsense_Mutation	315/862	p.R315*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Frame_Shift_Del	287-288/862	p.R287Sfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Frame_Shift_Ins	247-248/862	p.S248Vfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Frame_Shift_Del	246-247/862	p.P246*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Splice_Site	180/862	p.X180_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Splice_Site	55/862	p.X55_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
PMS2	Missense_Mutation	46/862	p.S46I	SAMPLE			True	True	Loss-of-function	Likely Oncogenic										18602922;23709753;17557300;24027009;2257789;27435373;16144131								
PMS2	Translation_Start_Site	1/862	p.M1?	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12697830;10439048;20487569;7628019;24362816;23582141;21376568;9500552;10874005;7892206;16144131;9488480								
POLD1	Missense_Mutation	474/1107	p.L474P	SAMPLE			True	False	Unknown																			
PPP2R1A	Frame_Shift_Ins	47/589	p.R48Pfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21435433;21791616;23639323;28940304;27485451;21381030								
PPP6C	Nonsense_Mutation	111/305	p.R111*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23729733;22817889;28658615;17079228;26868000;29758119;10227379;28481359								
PPP6C	Nonsense_Mutation	38/305	p.E38*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23729733;22817889;28658615;17079228;26868000;29758119;10227379;28481359								
PRDM1	Frame_Shift_Del	1/825	p.M1?	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20651244;27568520;16424392;21156281;16492805								
PRDM1	Splice_Site	14/825	p.X14_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20651244;27568520;16424392;21156281;16492805								
PRDM1	Frame_Shift_Del	25/825	p.R25Sfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20651244;27568520;16424392;21156281;16492805								
PRDM1	Nonsense_Mutation	27/825	p.Q27*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20651244;27568520;16424392;21156281;16492805								
PRDM1	Frame_Shift_Del	31/825	p.E31Gfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20651244;27568520;16424392;21156281;16492805								
PTCH1	Frame_Shift_Del	1398/1447	p.C1398Sfs*54	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Sonidegib						LEVEL_3A	24840883;22670903;8782823;24523439;24900187								
PTCH1	Frame_Shift_Ins	1394/1447	p.R1394Pfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Sonidegib						LEVEL_3A	24840883;22670903;8782823;24523439;24900187								
PTCH1	Frame_Shift_Del	1122/1447	p.M1122Vfs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Sonidegib						LEVEL_3A	24840883;22670903;8782823;24523439;24900187								
PTCH1	Frame_Shift_Del	960/1447	p.R960Gfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Sonidegib						LEVEL_3A	24840883;22670903;8782823;24523439;24900187								
PTCH1	Splice_Site	902/1447	p.X902_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Sonidegib						LEVEL_3A	24840883;22670903;8782823;24523439;24900187								
PTCH1	Nonsense_Mutation	794/1447	p.Q794*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Sonidegib						LEVEL_3A	24840883;22670903;8782823;24523439;24900187								
PTCH1	Frame_Shift_Del	274/1447	p.Q274Kfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Sonidegib						LEVEL_3A	24840883;22670903;8782823;24523439;24900187								
PTCH1	Splice_Site	132/1447	p.X132_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Sonidegib						LEVEL_3A	24840883;22670903;8782823;24523439;24900187								
PTCH1	Frame_Shift_Del	31-33/1447	p.G31Afs*47	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic			Sonidegib						LEVEL_3A	24840883;22670903;8782823;24523439;24900187								
PTEN	Frame_Shift_Ins	15-16/403	p.Y16Lfs*28	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					GSK2636771,AZD8186				LEVEL_4	17218262;11237521;28645941;Hansen et al. Abstract# 2570, ASCO 2017(http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2570)			TLL	LEVEL_Dx3				
PTEN	Missense_Mutation	96/403	p.P96L	SAMPLE		Y	True	True	Likely Loss-of-function	Likely Oncogenic					GSK2636771,AZD8186				LEVEL_4	21828076;28645941;Hansen et al. Abstract# 2570, ASCO 2017(http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2570)			TLL	LEVEL_Dx3				
PTEN	Frame_Shift_Del	182-183/403	p.K183Efs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					GSK2636771,AZD8186				LEVEL_4	17218262;11237521;28645941;Hansen et al. Abstract# 2570, ASCO 2017(http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2570)			TLL	LEVEL_Dx3				
PTEN	Nonsense_Mutation	233/403	p.R233*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					GSK2636771,AZD8186				LEVEL_4	17218262;11237521;28645941;Hansen et al. Abstract# 2570, ASCO 2017(http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.2570)			TLL	LEVEL_Dx3				
PTPN11	Missense_Mutation	63/593	p.Y63C	SAMPLE			True	True	Gain-of-function	Likely Oncogenic										15834506		JMML		LEVEL_Dx2				
PTPRD	Frame_Shift_Del	1830-1831/1912	p.K1831Nfs*24	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19478061;25113440								
PTPRD	Splice_Site	823/1912	p.X823_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19478061;25113440								
PTPRD	Frame_Shift_Ins	679-680/1912	p.W680Mfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19478061;25113440								
PTPRS	Frame_Shift_Ins	1024-1025/1948	p.V1025Rfs*34	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19000305;29915291								
PTPRS	Splice_Site	784/1948	p.X784_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19000305;29915291								
PTPRS	Frame_Shift_Del	575-576/1948	p.T576Lfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19000305;29915291								
PTPRS	Frame_Shift_Ins	574-575/1948	p.P575Sfs*52	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19000305;29915291								
PTPRS	Splice_Site	199/1948	p.X199_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19000305;29915291								
PTPRS	Splice_Site	193/1948	p.X193_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19000305;29915291								
PTPRT	Frame_Shift_Del	1082-1084/1460	p.L1082Rfs*33	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20133777;21517784;15155950								
PTPRT	Frame_Shift_Ins	881/1460	p.R881Pfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20133777;21517784;15155950								
PTPRT	Splice_Site	726/1460	p.X726_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20133777;21517784;15155950								
RAD21	Frame_Shift_Del	545/631	p.G547Afs*65	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28116354;25006131								
RAD21	Splice_Site	48/631	p.X48_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28116354;25006131								
RAD50	Frame_Shift_Del	26-27/1312	p.F27Sfs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Splice_Site	43/1312	p.X43_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Splice_Site	44/1312	p.X44_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Splice_Site	71/1312	p.X71_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Del	108-109/1312	p.T109Nfs*20	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Ins	179/1312	p.S181Ffs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Del	229/1312	p.S229Rfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	278/1312	p.R278*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	401/1312	p.R401*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Del	423/1312	p.L424Efs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Ins	572-573/1312	p.Q575Tfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Splice_Site	598/1312	p.X598_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	625/1312	p.Y625*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	626/1312	p.E626*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	653/1312	p.S653*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Ins	719/1312	p.E723Gfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Ins	722/1312	p.K722Nfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Del	734/1312	p.M735*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Del	765-769/1312	p.D767Kfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Del	772/1312	p.E772Kfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	823/1312	p.R823*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Del	833/1312	p.Q833Rfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	882/1312	p.Q882*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Del	916/1312	p.T917Qfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Ins	931-932/1312	p.N934Kfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Del	976-977/1312	p.E977Lfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	1017/1312	p.W1017*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Del	1023/1312	p.L1024*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	1077/1312	p.R1077*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	1093/1312	p.R1093*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Frame_Shift_Del	1159/1312	p.D1159Vfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	1185/1312	p.R1185*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Splice_Site	1204-?/1312	p.X1204_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Splice_Site	1206/1312	p.X1206_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	1219/1312	p.E1219*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	1239/1312	p.R1239*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD50	Nonsense_Mutation	1257/1312	p.S1257*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12208847;16288216;21892167;14684699								
RAD51	Frame_Shift_Del	264/339	p.I265Sfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										28512217;28575658;18632222;28236982;28481359								
RAD51B	Nonsense_Mutation	8/384	p.R8*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	25368520;16778173;32343890								
RAD51B	Nonsense_Mutation	13/384	p.Q13*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	25368520;16778173;32343890								
RAD51B	Splice_Site	29/384	p.X29_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	25368520;16778173;32343890								
RAD51B	Nonsense_Mutation	37/384	p.E37*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	25368520;16778173;32343890								
RAD51B	Nonsense_Mutation	47/384	p.R47*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	26845104;25600502;32343890								
RAD51B	Nonsense_Mutation	68/384	p.Y68*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	25368520;16778173;32343890								
RAD51B	Splice_Site	106/384	p.X106_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	25368520;16778173;32343890								
RAD51B	Frame_Shift_Del	194/384	p.S194Ffs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	25368520;16778173;32343890								
RAD51B	Nonsense_Mutation	318/384	p.R318*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	25368520;16778173;32343890								
RAD51B	Splice_Site	346/384	p.X346_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	25368520;16778173;32343890								
RAD51C	Frame_Shift_Del	30/376	p.F32Sfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400963;20400964;21616938;32343890								
RAD51C	Nonsense_Mutation	33/376	p.Q33*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400963;20400964;21616938;32343890								
RAD51C	Frame_Shift_Del	119/376	p.T120Qfs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400963;20400964;21616938;32343890								
RAD51C	Frame_Shift_Ins	130/376	p.T132Nfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400963;20400964;21616938;32343890								
RAD51C	Nonsense_Mutation	133/376	p.Q133*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400963;20400964;21616938;32343890								
RAD51C	Frame_Shift_Ins	133/376	p.L134Ifs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400963;20400964;21616938;32343890								
RAD51C	Missense_Mutation	138/376	p.L138F	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400964;24141787;32343890								
RAD51C	Nonsense_Mutation	210/376	p.Y210*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400963;20400964;21616938;32343890								
RAD51C	Splice_Site	235/376	p.X235_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400963;20400964;21616938;32343890								
RAD51C	Splice_Site	236/376	p.X236_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400963;20400964;21616938;32343890								
RAD51C	Nonsense_Mutation	237/376	p.R237*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400963;20400964;21616938;32343890								
RAD51C	Missense_Mutation	258/376	p.R258H	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400963;22167183;24141787;32343890								
RAD51C	Splice_Site	302/376	p.X302_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	20400963;20400964;21616938;32343890								
RAD51D	Nonsense_Mutation	156/216	p.W156*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	22986143;21822267;23372765;32343890								
RAD51D	Nonsense_Mutation	141/216	p.R141*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	22986143;21822267;23372765;32343890								
RAD51D	Frame_Shift_Del	138/216	p.H138Tfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	22986143;21822267;23372765;32343890								
RAD51D	Nonsense_Mutation	120/216	p.R120*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	22986143;21822267;23372765;32343890								
RAD51D	Nonsense_Mutation	80/216	p.Q80*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	22986143;21822267;23372765;32343890								
RAD51D	Nonsense_Mutation	74/216	p.R74*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	22986143;21822267;23372765;32343890								
RAD51D	Frame_Shift_Del	32/216	p.V32Ffs*30	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	22986143;21822267;23372765;32343890								
RAD51D	Splice_Site	28/216	p.X28_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Olaparib,Olaparib								LEVEL_1	22986143;21822267;23372765;32343890								
RAF1	Missense_Mutation	257/648	p.S257W	SAMPLE	Y		True	True	Gain-of-function	Likely Oncogenic			Cobimetinib						LEVEL_3A	12077328;7867061;17603483;29236635;30867592								
RASA1	Frame_Shift_Del	47/1047	p.Y49Ifs*24	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										2173144;9034330;9121432;1689011;24038909								
RASA1	Nonsense_Mutation	339/1047	p.V339_G340ins*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										2173144;9034330;9121432;1689011;24038909								
RASA1	Frame_Shift_Ins	425-426/1047	p.Y426Lfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										2173144;9034330;9121432;1689011;24038909								
RASA1	Nonsense_Mutation	553/1047	p.Y553*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										2173144;9034330;9121432;1689011;24038909								
RASA1	Frame_Shift_Del	841-843/1047	p.N842Ifs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										2173144;9034330;9121432;1689011;24038909								
RB1	Frame_Shift_Ins	37/928	p.E40Afs*27	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Frame_Shift_Del	151/928	p.L152*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Splice_Site	240/928	p.X240_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Nonsense_Mutation	255/928	p.R255*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Nonsense_Mutation	266/928	p.Q266*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Frame_Shift_Ins	280/928	p.H281Tfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Splice_Site	313/928	p.X313_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Nonsense_Mutation	358/928	p.R358*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Splice_Site	405/928	p.X405_splice	SAMPLE	Y		True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Nonsense_Mutation	444/928	p.Q444*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Splice_Site	445/928	p.X445_splice	SAMPLE	Y		True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Nonsense_Mutation	445/928	p.R445*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Splice_Site	474/928	p.X474_splice	SAMPLE	Y		True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Nonsense_Mutation	523/928	p.L523*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Nonsense_Mutation	533/928	p.E533*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Frame_Shift_Del	543/928	p.R544Efs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Frame_Shift_Del	543-544/928	p.E545Nfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Frame_Shift_Ins	584-585/928	p.L586Tfs*26	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Missense_Mutation	661/928	p.R661W	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										26925970;16449662;16269091;9420334;1352883;18677112;17096365								
RB1	Frame_Shift_Ins	707-708/928	p.K713Mfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Frame_Shift_Del	745-747/928	p.E746Gfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Nonsense_Mutation	765/928	p.K765*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RB1	Frame_Shift_Ins	788/928	p.R798Qfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31138663;30206110;14769601;26607597;22205104								
RECQL	Frame_Shift_Del	528-529/649	p.R528Sfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Nonsense_Mutation	519/649	p.W519*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Frame_Shift_Ins	516-517/649	p.D517*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Nonsense_Mutation	509/649	p.K509*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Frame_Shift_Del	505/649	p.E505Dfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Frame_Shift_Ins	497/649	p.I497Nfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Frame_Shift_Del	490/649	p.T490Rfs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Splice_Site	452/649	p.X452_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Nonsense_Mutation	407/649	p.R407*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Frame_Shift_Del	385-386/649	p.F385Lfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Nonsense_Mutation	380/649	p.K380*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Splice_Site	367/649	p.X367_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Splice_Site	366/649	p.X366_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Frame_Shift_Del	327/649	p.S327*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Frame_Shift_Del	321-322/649	p.C321Ffs*46	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Nonsense_Mutation	266/649	p.Q266*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Nonsense_Mutation	215/649	p.R215*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Frame_Shift_Del	44-45/649	p.K45*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Frame_Shift_Del	40/649	p.V41Sfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL	Frame_Shift_Del	30/649	p.E30Kfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29351780;25945795;15899892;25915596;26125302;28481359								
RECQL4	Frame_Shift_Ins	1162/1208	p.R1162Pfs*65	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Splice_Site	1132/1208	p.X1132_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Splice_Site	1131/1208	p.X1131_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	1123/1208	p.Q1123*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Ins	1096/1208	p.S1097Afs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Ins	1096/1208	p.R1096Pfs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	1093/1208	p.D1093Mfs*57	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	1047-1048/1208	p.K1048Gfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	1043/1208	p.L1043*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	1024-1025/1208	p.V1026Afs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	1024/1208	p.V1026Cfs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Splice_Site	1019/1208	p.X1019_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	998/1208	p.W998*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	966/1208	p.L966*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Splice_Site	962/1208	p.X962_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	957/1208	p.Q957*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	955/1208	p.Q955*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Splice_Site	919/1208	p.X919_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	907/1208	p.Q907*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	888/1208	p.Q888*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	884/1208	p.Q884Sfs*64	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	879/1208	p.P879Lfs*69	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	851/1208	p.P851Qfs*97	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	831/1208	p.H831Rfs*52	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	826/1208	p.R826*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Splice_Site	822/1208	p.X822_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	805-807/1208	p.G806*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	758/1208	p.R758*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	757/1208	p.Q757*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Ins	750/1208	p.S750Kfs*59	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	721/1208	p.R721*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	695/1208	p.K695Nfs*148	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	693/1208	p.Q693*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	654/1208	p.Q654*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	587/1208	p.A587Rfs*103	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	567/1208	p.Q567*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	563/1208	p.E563*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	525/1208	p.C525Afs*33	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	509-510/1208	p.L510Afs*47	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Splice_Site	464/1208	p.X464_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Splice_Site	420/1208	p.X420_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	412/1208	p.W412*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	407/1208	p.E407*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	389/1208	p.C389Ffs*33	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	363/1208	p.Y363*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	360/1208	p.Q360*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	350/1208	p.R350Gfs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	338-339/1208	p.L339Afs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	291/1208	p.A291Lfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	269/1208	p.W269Gfs*24	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	230-237/1208	p.G231Rfs*58	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	120-125/1208	p.G120Afs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Splice_Site	?-121/1208	p.X119_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	107/1208	p.Q107*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Nonsense_Mutation	105/1208	p.Y105*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	53/1208	p.G53Afs*30	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RECQL4	Frame_Shift_Del	48/1208	p.L48Qfs*88	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12734318;15897384;23842644;18716613;28481359								
RET	Missense_Mutation	533/1114	p.G533C	SAMPLE			True	False	Unknown																			
RET	Missense_Mutation	620/1114	p.C620Y	SAMPLE			True	False	Likely Gain-of-function	Likely Oncogenic	Selpercatinib,Pralsetinib								LEVEL_1	9230192;Wirth et al. Abstract# LBA93, ESMO2019(https://www.sciencedirect.com/science/article/pii/S0923753419604539);29657135;Taylor et al. Abstract# 6018, ASCO 2019(https://meetinglibrary.asco.org/record/174787/abstract);Hu et al. Abstract# 19130, ESMO 2020(https://oncologypro.esmo.org/meeting-resources/esmo-virtual-congress-2020/results-from-the-registrational-phase-i-ii-arrow-trial-of-pralsetinib-blu-667-in-patients-pts-with-advanced-ret-mutation-positive-medullary-thy)								
RET	Missense_Mutation	634/1114	p.C634Y	SAMPLE			True	True	Gain-of-function	Likely Oncogenic	Selpercatinib,Pralsetinib								LEVEL_1	9230192;Wirth et al. Abstract# LBA93, ESMO2019(https://www.sciencedirect.com/science/article/pii/S0923753419604539);29657135;Taylor et al. Abstract# 6018, ASCO 2019(https://meetinglibrary.asco.org/record/174787/abstract);Hu et al. Abstract# 19130, ESMO 2020(https://oncologypro.esmo.org/meeting-resources/esmo-virtual-congress-2020/results-from-the-registrational-phase-i-ii-arrow-trial-of-pralsetinib-blu-667-in-patients-pts-with-advanced-ret-mutation-positive-medullary-thy)								
RET	Missense_Mutation	790/1114	p.L790F	SAMPLE			True	True	Gain-of-function	Oncogenic	Selpercatinib,Pralsetinib								LEVEL_1	15753368;20444924;Wirth et al. Abstract# LBA93, ESMO2019(https://www.sciencedirect.com/science/article/pii/S0923753419604539);29657135;Taylor et al. Abstract# 6018, ASCO 2019(https://meetinglibrary.asco.org/record/174787/abstract);Hu et al. Abstract# 19130, ESMO 2020(https://oncologypro.esmo.org/meeting-resources/esmo-virtual-congress-2020/results-from-the-registrational-phase-i-ii-arrow-trial-of-pralsetinib-blu-667-in-patients-pts-with-advanced-ret-mutation-positive-medullary-thy)								
RET	Missense_Mutation	804/1114	p.V804M	SAMPLE			True	True	Gain-of-function	Oncogenic	Selpercatinib,Pralsetinib								LEVEL_1	17047083;Wirth et al. JCO PO, 2019(https://ascopubs.org/doi/full/10.1200/PO.19.00189);Wirth et al. Abstract# LBA93, ESMO2019(https://www.sciencedirect.com/science/article/pii/S0923753419604539);29657135;Taylor et al. Abstract# 6018, ASCO 2019(https://meetinglibrary.asco.org/record/174787/abstract);Hu et al. Abstract# 19130, ESMO 2020(https://oncologypro.esmo.org/meeting-resources/esmo-virtual-congress-2020/results-from-the-registrational-phase-i-ii-arrow-trial-of-pralsetinib-blu-667-in-patients-pts-with-advanced-ret-mutation-positive-medullary-thy)								
RET	Missense_Mutation	918/1114	p.M918T	SAMPLE	Y		True	True	Gain-of-function	Oncogenic	Selpercatinib,Pralsetinib								LEVEL_1	9681850;24561444;8755580;22584710;7824936;Wirth et al. Abstract# LBA93, ESMO2019(https://www.sciencedirect.com/science/article/pii/S0923753419604539);29657135;Taylor et al. Abstract# 6018, ASCO 2019(https://meetinglibrary.asco.org/record/174787/abstract);Hu et al. Abstract# 19130, ESMO 2020(https://oncologypro.esmo.org/meeting-resources/esmo-virtual-congress-2020/results-from-the-registrational-phase-i-ii-arrow-trial-of-pralsetinib-blu-667-in-patients-pts-with-advanced-ret-mutation-positive-medullary-thy)								
RNF43	Frame_Shift_Ins	698-699/783	p.I700Dfs*47	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23847203;23096461;25344691								
RNF43	Frame_Shift_Ins	659/783	p.P660Sfs*87	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23847203;23096461;25344691								
RNF43	Nonsense_Mutation	650/783	p.R650*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23847203;23096461;25344691								
RNF43	Nonsense_Mutation	590/783	p.E590*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23847203;23096461;25344691								
RNF43	Nonsense_Mutation	371/783	p.R371*	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										23847203;23096461;25344691								
RNF43	Frame_Shift_Del	270/783	p.P270Rfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23847203;23096461;25344691								
RNF43	Nonsense_Mutation	249/783	p.Q249*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23847203;23096461;25344691								
RTEL1	Nonsense_Mutation	140/1243	p.W140*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31762827;18957201;23329068;29625055;21097466;28507545;20507306								
RTEL1	Nonsense_Mutation	148/1243	p.R148*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31762827;18957201;23329068;29625055;21097466;28507545;20507306								
RTEL1	Frame_Shift_Del	379/1243	p.A379Pfs*99	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31762827;18957201;23329068;29625055;21097466;28507545;20507306								
RTEL1	Missense_Mutation	516/1243	p.M516I	SAMPLE			True	False	Unknown																			
RTEL1	Splice_Site	556/1243	p.X556_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31762827;18957201;23329068;29625055;21097466;28507545;20507306								
RTEL1	Frame_Shift_Del	773/1243	p.R774Vfs*50	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31762827;18957201;23329068;29625055;21097466;28507545;20507306								
RTEL1	Nonsense_Mutation	933/1243	p.Q933*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31762827;18957201;23329068;29625055;21097466;28507545;20507306								
RTEL1	Nonsense_Mutation	1010/1243	p.R1010*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31762827;18957201;23329068;29625055;21097466;28507545;20507306								
RTEL1	Nonsense_Mutation	1043/1243	p.Q1043*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31762827;18957201;23329068;29625055;21097466;28507545;20507306								
RTEL1	Splice_Site	1061/1243	p.X1061_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										31762827;18957201;23329068;29625055;21097466;28507545;20507306								
RUNX1	Splice_Site	33/480	p.X33_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										17394134;15864279;15386419	AMLRUNX1	MDS,CMML	ETPLL	LEVEL_Dx1	MDS,AML			LEVEL_Px1
SDHA	Translation_Start_Site	1/664	p.M1?	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Nonsense_Mutation	31/664	p.R31*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Splice_Site	50/664	p.X50_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Frame_Shift_Ins	57/664	p.V58Sfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Nonsense_Mutation	75/664	p.R75*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Frame_Shift_Del	82-84/664	p.E82Vfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Nonsense_Mutation	152/664	p.E152*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Nonsense_Mutation	185/664	p.Q185*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Frame_Shift_Del	222/664	p.D223Ifs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Frame_Shift_Del	229/664	p.E230Sfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Frame_Shift_Del	233/664	p.V234Sfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Nonsense_Mutation	384/664	p.S384*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Frame_Shift_Del	446/664	p.H447Mfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHA	Frame_Shift_Ins	479/664	p.K480Vfs*16	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21752896;22974104								
SDHAF2	Splice_Site	87/166	p.X87_splice	SAMPLE	Y		True	True	Likely Loss-of-function	Likely Oncogenic										20226277;31039394;28099933;29625055;31687641;28384794								
SDHAF2	Nonsense_Mutation	105/166	p.Y105*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20226277;31039394;28099933;29625055;31687641;28384794								
SDHAF2	Frame_Shift_Ins	118/166	p.Y119Lfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20226277;31039394;28099933;29625055;31687641;28384794								
SDHAF2	Splice_Site	124/166	p.X124_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20226277;31039394;28099933;29625055;31687641;28384794								
SDHAF2	Frame_Shift_Del	147/166	p.N148Tfs*35	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20226277;31039394;28099933;29625055;31687641;28384794								
SDHAF2	Frame_Shift_Del	149/166	p.K149Rfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20226277;31039394;28099933;29625055;31687641;28384794								
SDHB	Missense_Mutation	242/280	p.R242H	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										25972245;25025441;17102084;12213855;22270996;12000816;21173220;25736212;24276837								
SDHB	Missense_Mutation	230/280	p.R230C	SAMPLE			True	False	Unknown																			
SDHB	Nonsense_Mutation	214/280	p.Q214*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14500403;18978332								
SDHB	Frame_Shift_Ins	203-204/280	p.D204Tfs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14500403;18978332								
SDHB	Missense_Mutation	200/280	p.W200C	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										20119652;21173220;17200167;22835832;19184535;17143317								
SDHB	Frame_Shift_Del	197/280	p.S198Afs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14500403;18978332								
SDHB	Missense_Mutation	197/280	p.P197R	SAMPLE			True	False	Unknown																			
SDHB	Missense_Mutation	196/280	p.C196Y	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										23666964;24781345;22835832;25494863;12000816;25683602;21172883								
SDHB	Nonsense_Mutation	176/280	p.E176*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14500403;18978332								
SDHB	Missense_Mutation	140/280	p.V140F	SAMPLE			True	False	Unknown																			
SDHB	Missense_Mutation	127/280	p.I127S	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										19215943;15987702;16916404;23282968;16912137;17200167;19001511;25683602								
SDHB	Splice_Site	96/280	p.X96_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14500403;18978332								
SDHB	Nonsense_Mutation	90/280	p.R90*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14500403;18978332								
SDHB	Frame_Shift_Del	56-57/280	p.P56Yfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14500403;18978332								
SDHB	Nonsense_Mutation	47/280	p.W47*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14500403;18978332								
SDHB	Missense_Mutation	46/280	p.R46Q	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										23083876;22835832;26719882;12618761;18362451;23282968;15328326;14500403								
SDHB	Splice_Site	24/280	p.X24_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14500403;18978332								
SDHC	Translation_Start_Site	1/169	p.M1?	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27700540;28819017;16249420								
SDHC	Nonsense_Mutation	15/169	p.R15*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27700540;28819017;16249420								
SDHC	Splice_Site	135/169	p.X135_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27700540;28819017;16249420								
SDHD	Frame_Shift_Ins	18/159	p.L19Sfs*50	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20226277;31039394;12883710;28099933;12111639;29545045								
SDHD	Frame_Shift_Del	56-57/159	p.S57Wfs*11	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20226277;31039394;12883710;28099933;12111639;29545045								
SDHD	Missense_Mutation	81/159	p.P81L	SAMPLE			True	False	Unknown																			
SDHD	Frame_Shift_Ins	129/159	p.A130Gfs*61	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										20226277;31039394;12883710;28099933;12111639;29545045								
SESN1	Frame_Shift_Ins	459/551	p.M459Nfs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18692468;29625055;30318520;25263562;24055102;29511169								
SESN1	Frame_Shift_Del	422/551	p.L422Wfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18692468;29625055;30318520;25263562;24055102;29511169								
SESN1	Splice_Site	325/551	p.X325_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18692468;29625055;30318520;25263562;24055102;29511169								
SESN1	Frame_Shift_Del	13-14/551	p.C14Qfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18692468;29625055;30318520;25263562;24055102;29511169								
SESN2	Splice_Site	404/480	p.X404_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18692468;25457612;29625055;24055102;27463837								
SESN2	Frame_Shift_Del	412/480	p.V413*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18692468;25457612;29625055;24055102;27463837								
SESN2	Nonsense_Mutation	437/480	p.R437*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18692468;25457612;29625055;24055102;27463837								
SESN3	Nonsense_Mutation	57/492	p.E57*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18692468;25457612;29625055;24055102;27463837;22958918								
SETD2	Nonsense_Mutation	7/2564	p.Q7*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										25728682;24509477;23417712								
SF3B1	Missense_Mutation	666/1304	p.K666T	SAMPLE	Y		True	True	Switch-of-function	Likely Oncogenic					H3B-8800,H3B-8800,H3B-8800				LEVEL_4	24434863;26842708;29457796;Buonamici, S. et al. Abstract# Blood 128:966, 2016(http://www.bloodjournal.org/content/128/22/966?sso-checked=true)		MDS,MDSRS,MDSMPNRST	CLLSLL	LEVEL_Dx2	MDS,MDSMPNRST	ET		LEVEL_Px1
SH2B3	Splice_Site	244/575	p.X244_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21922527;26974155;29625055;30254368;25776072;28484264			ETPLL	LEVEL_Dx3		ET		LEVEL_Px2
SH2B3	Nonsense_Mutation	258/575	p.Q258*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21922527;26974155;29625055;30254368;25776072;28484264			ETPLL	LEVEL_Dx3		ET		LEVEL_Px2
SH2B3	Splice_Site	278/575	p.X278_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21922527;26974155;29625055;30254368;25776072;28484264			ETPLL	LEVEL_Dx3		ET		LEVEL_Px2
SH2B3	Frame_Shift_Ins	344-345/575	p.L347Afs*38	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21922527;26974155;29625055;30254368;25776072;28484264			ETPLL	LEVEL_Dx3		ET		LEVEL_Px2
SH2B3	Frame_Shift_Del	419-420/575	p.E420Afs*35	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21922527;26974155;29625055;30254368;25776072;28484264			ETPLL	LEVEL_Dx3		ET		LEVEL_Px2
SHQ1	Nonsense_Mutation	475/577	p.S475*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Nonsense_Mutation	433/577	p.E433*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Frame_Shift_Del	323/577	p.S323Lfs*18	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Splice_Site	312/577	p.X312_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Frame_Shift_Del	276-277/577	p.D277Sfs*27	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Nonsense_Mutation	224/577	p.S224*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Frame_Shift_Del	204/577	p.F204Lfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Nonsense_Mutation	182/577	p.R182*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Splice_Site	163/577	p.X163_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Splice_Site	162/577	p.X162_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Nonsense_Mutation	154/577	p.R154*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Frame_Shift_Del	118/577	p.V119*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Splice_Site	111/577	p.X111_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Splice_Site	70/577	p.X70_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SHQ1	Frame_Shift_Del	37-43/577	p.D37Sfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										12228251;20579941;19383767								
SLX4	Nonsense_Mutation	1733/1834	p.E1733*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	1666/1834	p.R1666*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	1637/1834	p.S1637*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Frame_Shift_Ins	1587-1588/1834	p.K1588*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	1441/1834	p.W1441*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	1428/1834	p.W1428*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Frame_Shift_Del	1363-1364/1834	p.D1365Pfs*26	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Frame_Shift_Del	1319/1834	p.Q1319Rfs*56	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Frame_Shift_Del	1236-1237/1834	p.W1236Cfs*51	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	1139/1834	p.Q1139*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	1054/1834	p.S1054*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Frame_Shift_Del	944/1834	p.P944Rfs*35	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	866/1834	p.Q866*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	862/1834	p.R862*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	823/1834	p.W823*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	795/1834	p.S795*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Splice_Site	721/1834	p.X721_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	713/1834	p.R713*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Frame_Shift_Del	637-639/1834	p.E638Lfs*13	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Frame_Shift_Ins	636/1834	p.S637Tfs*19	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	610/1834	p.Q610*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Frame_Shift_Del	530/1834	p.L530Vfs*45	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Frame_Shift_Ins	142/1834	p.V143Cfs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SLX4	Nonsense_Mutation	34/1834	p.Q34*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19596235;21240275;19596236;23211700;29625055;19595721;23840564								
SMAD3	Frame_Shift_Del	240-241/425	p.L240Pfs*69	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11691834								
SMAD3	Nonsense_Mutation	322/425	p.Q322*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11691834								
SMAD3	Splice_Site	337/425	p.X337_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11691834								
SMAD4	Nonsense_Mutation	138/552	p.S138*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23139211;10340381;11553622;15711891;9094310								
SMAD4	Nonsense_Mutation	301/552	p.Y301*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23139211;10340381;11553622;15711891;9094310								
SMARCA4	Frame_Shift_Del	100-101/1647	p.G102Pfs*26	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24658002;24658001;24658004;25060813;18301784								
SMARCA4	Frame_Shift_Del	585-586/1647	p.K586Rfs*26	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24658002;24658001;24658004;25060813;18301784								
SMARCA4	Nonsense_Mutation	763/1647	p.E763*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24658002;24658001;24658004;25060813;18301784								
SMARCA4	Splice_Site	813/1647	p.X813_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24658002;24658001;24658004;25060813;18301784								
SMARCA4	Nonsense_Mutation	1493/1647	p.E1493*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24658002;24658001;24658004;25060813;18301784								
SMARCA4	Nonsense_Mutation	1637/1647	p.E1637*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24658002;24658001;24658004;25060813;18301784								
SMARCB1	Nonsense_Mutation	158/385	p.R158*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					Tazemetostat				LEVEL_4	23435428;21076395;23620515;12138206;30755442;9671307;29650362;20951942;27391784;Chi et al. Abstract# A175, AACR-NCI-EORTC 2017(http://www.abstractsonline.com/pp8/#!/4557/presentation/616)								
SMARCB1	Splice_Site	167/385	p.X167_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					Tazemetostat				LEVEL_4	23435428;21076395;23620515;12138206;30755442;9671307;29650362;20951942;27391784;Chi et al. Abstract# A175, AACR-NCI-EORTC 2017(http://www.abstractsonline.com/pp8/#!/4557/presentation/616)								
SMARCB1	Splice_Site	265/385	p.X265_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic					Tazemetostat				LEVEL_4	23435428;21076395;23620515;12138206;30755442;9671307;29650362;20951942;27391784;Chi et al. Abstract# A175, AACR-NCI-EORTC 2017(http://www.abstractsonline.com/pp8/#!/4557/presentation/616)								
SOX17	Frame_Shift_Ins	326/414	p.G331Rfs*34	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										17875931;23550210;22588877;27738313;28237397								
SPEN	Frame_Shift_Del	2043-2046/3664	p.D2044Cfs*9	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										26297734								
SPOP	Nonsense_Mutation	237/374	p.K237*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										30068710;29625055;22610119;28292441;28414305;31495053;26374986;30237511								
SPOP	Splice_Site	67/374	p.X67_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										30068710;29625055;22610119;28292441;28414305;31495053;26374986;30237511								
STAG2	Frame_Shift_Ins	926/1268	p.N928*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21852505;24121789;22417201;25010205		MDS		LEVEL_Dx2				
STAT3	Missense_Mutation	582/770	p.E582K	SAMPLE			True	False	Unknown																			
STK11	Nonsense_Mutation	137/433	p.Q137*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24652667;19892943;25079552;21516316;19340305								
STK11	Nonsense_Mutation	210/433	p.C210*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24652667;19892943;25079552;21516316;19340305								
STK11	Nonsense_Mutation	382/433	p.Q382*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24652667;19892943;25079552;21516316;19340305								
SUFU	Frame_Shift_Ins	22/484	p.A25Gfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										10806483;17102621;29625055;22958902;10564661;10559945;12068298								
SUFU	Splice_Site	341/484	p.X341_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										10806483;17102621;29625055;22958902;10564661;10559945;12068298								
TBX3	Frame_Shift_Ins	609-610/743	p.A610Wfs*24	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11689487;26579496								
TBX3	Splice_Site	367/743	p.X367_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11689487;26579496								
TCF3	Splice_Site	73/651	p.X73_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24832538;25729575;30063982;29625055;28532655;17018284;25990863;27461063;31575852			BL	LEVEL_Dx3				
TCF7L2	Splice_Site	128/602	p.X128_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18599616;10485457;10919662;16547505;18478343								
TCF7L2	Nonsense_Mutation	150/602	p.Q150*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18599616;10485457;10919662;16547505;18478343								
TCF7L2	Frame_Shift_Ins	465/602	p.C469Vfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18599616;10485457;10919662;16547505;18478343								
TCF7L2	Frame_Shift_Del	494/602	p.S496Pfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18599616;10485457;10919662;16547505;18478343								
TCF7L2	Nonsense_Mutation	505/602	p.R505*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18599616;10485457;10919662;16547505;18478343								
TCF7L2	Frame_Shift_Del	567/602	p.S569Pfs*33	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18599616;10485457;10919662;16547505;18478343								
TERT	Missense_Mutation	694/1132	p.V694M	SAMPLE			True	False	Unknown																			
TERT	Missense_Mutation	486/1132	p.R486C	SAMPLE			True	False	Unknown																			
TET1	Frame_Shift_Del	93/2136	p.P94Qfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22156206;21057493;19372391								
TET1	Splice_Site	1802/2136	p.X1802_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										22156206;21057493;19372391								
TET2	Nonsense_Mutation	108/2002	p.Q108*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Frame_Shift_Del	121/2002	p.R122Dfs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Frame_Shift_Del	133/2002	p.P133Qfs*12	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Nonsense_Mutation	354/2002	p.S354*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Frame_Shift_Ins	518/2002	p.G520Wfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Nonsense_Mutation	642/2002	p.Q642*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Frame_Shift_Ins	658/2002	p.H658Qfs*23	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Nonsense_Mutation	1216/2002	p.R1216*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Frame_Shift_Del	1244/2002	p.Y1245Lfs*22	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Frame_Shift_Ins	1247-1248/2002	p.E1250Lfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Frame_Shift_Ins	1270/2002	p.C1271Lfs*29	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Nonsense_Mutation	1271/2002	p.C1271*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Frame_Shift_Del	1332/2002	p.M1333Wfs*30	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Nonsense_Mutation	1435/2002	p.Q1435*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TET2	Nonsense_Mutation	1751-1752/2002	p.Y1751_K1752delins*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										24315485;21057493		CMML,MDS	AITL	LEVEL_Dx2				
TGFBR1	Splice_Site	192/503	p.X192_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11212236;10656986								
TGFBR1	Frame_Shift_Del	327/503	p.P327Qfs*8	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11212236;10656986								
TGFBR1	Missense_Mutation	487/503	p.R487W	SAMPLE	Y		True	True	Likely Loss-of-function	Likely Oncogenic										25116393;16791849;16928994								
TGFBR2	Splice_Site	32/592	p.X32_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11309634;16310402;17456004;17985359;9927040;7585632								
TGFBR2	Frame_Shift_Ins	150/592	p.P154Afs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11309634;16310402;17456004;17985359;9927040;7585632								
TGFBR2	Frame_Shift_Del	150/592	p.K153Sfs*35	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11309634;16310402;17456004;17985359;9927040;7585632								
TGFBR2	Nonsense_Mutation	341/592	p.E341*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										11309634;16310402;17456004;17985359;9927040;7585632								
TMEM127	Splice_Site	137/238	p.X137_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29547888;29625055;20154675;21156949;29282712								
TMEM127	Frame_Shift_Del	133/238	p.H133Ifs*3	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29547888;29625055;20154675;21156949;29282712								
TMEM127	Frame_Shift_Del	103/238	p.G103Afs*21	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29547888;29625055;20154675;21156949;29282712								
TMEM127	Frame_Shift_Del	89-90/238	p.V90Afs*17	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29547888;29625055;20154675;21156949;29282712								
TMEM127	Splice_Site	82/238	p.X82_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29547888;29625055;20154675;21156949;29282712								
TNFRSF14	Nonsense_Mutation	83/283	p.Y83*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27982078;27103745;27257180;24307582;29625055;22017438;27297871;26650888;21402741;20884631;30066919;11742858			FL	LEVEL_Dx3				
TNFRSF14	Frame_Shift_Del	223/283	p.I223Mfs*10	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27982078;27103745;27257180;24307582;29625055;22017438;27297871;26650888;21402741;20884631;30066919;11742858			FL	LEVEL_Dx3				
TP53	Missense_Mutation	342/393	p.R342P	SAMPLE		Y	True	True	Loss-of-function	Likely Oncogenic										19454241;20978130					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Nonsense_Mutation	342/393	p.R342*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19336573;27759562;16007150;11753428;11900253;21467160					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	337/393	p.R337H	SAMPLE	Y	Y	True	True	Likely Loss-of-function	Likely Oncogenic										19454241;11481490;25584008					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	337/393	p.R337C	SAMPLE	Y	Y	True	True	Loss-of-function	Likely Oncogenic										19454241;17311302;16007150;19106109;11753428					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Splice_Site	307/393	p.X307_splice	SAMPLE	Y		True	True	Likely Loss-of-function	Likely Oncogenic										19336573;27759562;16007150;11753428;11900253;21467160					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Nonsense_Mutation	306/393	p.R306*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19336573;27759562;16007150;11753428;11900253;21467160					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	282/393	p.R282G	SAMPLE	Y	Y	True	True	Likely Loss-of-function	Likely Oncogenic										18453682					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	273/393	p.R273P	SAMPLE	Y	Y	True	True	Likely Loss-of-function	Likely Oncogenic										23863845;11900253;23612969;15037740					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	273/393	p.R273H	SAMPLE	Y	Y	True	True	Loss-of-function	Oncogenic										31776133;25584008;26181206;15037740					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	267/393	p.R267W	SAMPLE	Y		True	False	Likely Gain-of-function	Likely Oncogenic										22989750;23264849					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Nonsense_Mutation	266/393	p.G266*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19336573;27759562;16007150;11753428;11900253;21467160					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	252/393	p.L252P	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										8023157;11900253					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	248/393	p.R248L	SAMPLE	Y	Y	True	True	Likely Loss-of-function	Likely Oncogenic										26748848;25584008					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	248/393	p.R248Q	SAMPLE	Y	Y	True	True	Likely Loss-of-function	Likely Oncogenic										24814347;16778209;21445056					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	248/393	p.R248W	SAMPLE	Y	Y	True	True	Loss-of-function	Likely Oncogenic										25584008;18762571;10229196					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	245/393	p.G245S	SAMPLE	Y	Y	True	True	Loss-of-function	Oncogenic										2358418;15037740					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	238/393	p.C238S	SAMPLE	Y	Y	True	True	Loss-of-function	Likely Oncogenic										19681600					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Frame_Shift_Del	222/393	p.P222Rfs*25	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19336573;27759562;16007150;11753428;11900253;21467160					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Frame_Shift_Del	214-215/393	p.H214Qfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19336573;27759562;16007150;11753428;11900253;21467160					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	213/393	p.R213Q	SAMPLE			True	True	Loss-of-function	Likely Oncogenic										10871862					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	205/393	p.Y205C	SAMPLE	Y		True	True	Loss-of-function	Likely Oncogenic										15037740					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Nonsense_Mutation	196/393	p.R196*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19336573;27759562;16007150;11753428;11900253;21467160					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	181/393	p.R181H	SAMPLE	Y	Y	True	True	Loss-of-function	Likely Oncogenic										20471942					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	179/393	p.H179Y	SAMPLE	Y	Y	True	True	Loss-of-function	Likely Oncogenic										17530187					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	176/393	p.C176F	SAMPLE	Y	Y	True	True	Loss-of-function	Likely Oncogenic										22090360					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	175/393	p.R175H	SAMPLE	Y	Y	True	True	Loss-of-function	Oncogenic										25584008;15781620;22114072;10713666;21445056;31068365					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Nonsense_Mutation	165/393	p.Q165*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19336573;27759562;16007150;11753428;11900253;21467160					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	158/393	p.R158H	SAMPLE	Y		True	True	Loss-of-function	Likely Oncogenic										25584008;10229196					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	141/393	p.C141Y	SAMPLE	Y	Y	True	True	Likely Loss-of-function	Likely Oncogenic										15037740					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Missense_Mutation	135/393	p.C135R	SAMPLE	Y	Y	True	True	Likely Loss-of-function	Likely Oncogenic										17914575					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Nonsense_Mutation	103/393	p.Y103*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19336573;27759562;16007150;11753428;11900253;21467160					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Nonsense_Mutation	91/393	p.W91*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19336573;27759562;16007150;11753428;11900253;21467160					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Frame_Shift_Del	83-86/393	p.A83Hfs*37	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19336573;27759562;16007150;11753428;11900253;21467160					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53	Nonsense_Mutation	52/393	p.Q52*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										19336573;27759562;16007150;11753428;11900253;21467160					AMLMRC,AML,TMN,CLLSLL,MDS,ET,MPN,PMF		MCL	LEVEL_Px1
TP53BP1	Splice_Site	1769/1977	p.X1769_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23103855								
TP53BP1	Nonsense_Mutation	1722/1977	p.E1722*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23103855								
TP53BP1	Frame_Shift_Ins	1574/1977	p.Y1574Cfs*29	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23103855								
TP53BP1	Frame_Shift_Del	663/1977	p.G663Vfs*5	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23103855								
TP53BP1	Nonsense_Mutation	365/1977	p.S365*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23103855								
TP53BP1	Splice_Site	124/1977	p.X124_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										23103855								
TP63	Splice_Site	21/680	p.X21_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29481901;20556892;29625055;18364388;30283353;26374530;29885760;12368193;22158419;23686138								
TP63	Nonsense_Mutation	393/680	p.R393*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										29481901;20556892;29625055;18364388;30283353;26374530;29885760;12368193;22158419;23686138								
TSC1	Splice_Site	221/1164	p.X221_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Everolimus								LEVEL_1	23485365;24529379;20301399;23158522								
TSC2	Splice_Site	46-?/1807	p.X46_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Everolimus		ABI-009						LEVEL_1	24529379;14729330;25724664;14561707;23158522;Wagner et al. Abstract# 11516, ASCO 2020(https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.11516);Wagner et al. Abstract# 11005, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.11005)								
TSC2	Missense_Mutation	361/1807	p.L361V	SAMPLE			True	False	Unknown																			
TSC2	Missense_Mutation	705/1807	p.V705M	SAMPLE			True	True	Loss-of-function	Likely Oncogenic	Everolimus		ABI-009						LEVEL_1	22903760;23158522;Wagner et al. Abstract# 11516, ASCO 2020(https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.11516);Wagner et al. Abstract# 11005, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.11005)								
TSC2	Frame_Shift_Del	952/1807	p.K954Nfs*4	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Everolimus		ABI-009						LEVEL_1	24529379;14729330;25724664;14561707;23158522;Wagner et al. Abstract# 11516, ASCO 2020(https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.11516);Wagner et al. Abstract# 11005, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.11005)								
TSC2	Missense_Mutation	1200/1807	p.R1200W	SAMPLE			True	True	Loss-of-function	Likely Oncogenic	Everolimus		ABI-009						LEVEL_1	21332470;23158522;Wagner et al. Abstract# 11516, ASCO 2020(https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.11516);Wagner et al. Abstract# 11005, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.11005)								
TSC2	Frame_Shift_Del	1270/1807	p.N1270Tfs*55	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Everolimus		ABI-009						LEVEL_1	24529379;14729330;25724664;14561707;23158522;Wagner et al. Abstract# 11516, ASCO 2020(https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.11516);Wagner et al. Abstract# 11005, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.11005)								
TSC2	Frame_Shift_Ins	1278-1279/1807	p.Y1279Lfs*43	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Everolimus		ABI-009						LEVEL_1	24529379;14729330;25724664;14561707;23158522;Wagner et al. Abstract# 11516, ASCO 2020(https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.11516);Wagner et al. Abstract# 11005, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.11005)								
TSC2	Nonsense_Mutation	1286/1807	p.Q1286*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Everolimus		ABI-009						LEVEL_1	24529379;14729330;25724664;14561707;23158522;Wagner et al. Abstract# 11516, ASCO 2020(https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.11516);Wagner et al. Abstract# 11005, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.11005)								
TSC2	Splice_Site	?-1336/1807	p.X1336_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Everolimus		ABI-009						LEVEL_1	24529379;14729330;25724664;14561707;23158522;Wagner et al. Abstract# 11516, ASCO 2020(https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.11516);Wagner et al. Abstract# 11005, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.11005)								
TSC2	Nonsense_Mutation	1351/1807	p.E1351*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic	Everolimus		ABI-009						LEVEL_1	24529379;14729330;25724664;14561707;23158522;Wagner et al. Abstract# 11516, ASCO 2020(https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.11516);Wagner et al. Abstract# 11005, ASCO 2019(https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.11005)								
TSHR	Missense_Mutation	450/764	p.R450H	SAMPLE			True	False	Unknown																			
U2AF1	Missense_Mutation	157/240	p.Q157R	SAMPLE	Y		True	True	Likely Gain-of-function	Oncogenic					H3B-8800,H3B-8800,H3B-8800				LEVEL_4	30054334;25267526;31961934;25311244;29457796;Buonamici, S. et al. Abstract# Blood 128:966, 2016(http://www.bloodjournal.org/content/128/22/966?sso-checked=true)		MDS,MDSRS		LEVEL_Dx2		ET		LEVEL_Px2
VHL	Frame_Shift_Del	13/213	p.G14Afs*53	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21386872;12004076;12050673;22825683								
VHL	Nonsense_Mutation	23/213	p.Y23*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21386872;12004076;12050673;22825683								
VHL	Nonsense_Mutation	52/213	p.E52*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21386872;12004076;12050673;22825683								
VHL	Missense_Mutation	81/213	p.P81L	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										24446253;17102082;22241717								
VHL	Missense_Mutation	84/213	p.V84L	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										10823831;25078357;16502427;11331612;21463266;8592333								
VHL	Missense_Mutation	86/213	p.P86L	SAMPLE	Y	Y	True	True	Likely Loss-of-function	Likely Oncogenic										10823831;10535940								
VHL	Missense_Mutation	98/213	p.Y98H	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										10823831								
VHL	Missense_Mutation	107/213	p.R107P	SAMPLE			True	True	Likely Loss-of-function	Likely Oncogenic										22799452;19336503;12000816;12624160;9829911								
VHL	Nonsense_Mutation	113/213	p.R113*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										21386872;12004076;12050673;22825683								
VHL	Missense_Mutation	161/213	p.R161Q	SAMPLE	Y		True	True	Likely Loss-of-function	Likely Oncogenic										20960261;25371412;23404858;17102088;21362373;16314641;23842656								
VHL	Missense_Mutation	167/213	p.R167W	SAMPLE			True	True	Loss-of-function	Oncogenic										14973063;25563310;23824745;12202531								
WT1	Splice_Site	334/517	p.X334_splice	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										18591546;8618823;12796362;18559874;25110071						AML		LEVEL_Px2
XRCC2	Nonsense_Mutation	244/280	p.Q244*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14678973;10517641;22464251								
XRCC2	Nonsense_Mutation	217-218/280	p.C217*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14678973;10517641;22464251								
XRCC2	Nonsense_Mutation	215/280	p.R215*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14678973;10517641;22464251								
XRCC2	Frame_Shift_Ins	185/280	p.N185Kfs*2	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14678973;10517641;22464251								
XRCC2	Nonsense_Mutation	156/280	p.W156*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14678973;10517641;22464251								
XRCC2	Frame_Shift_Ins	117/280	p.L117Ffs*6	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14678973;10517641;22464251								
XRCC2	Nonsense_Mutation	64/280	p.R64*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14678973;10517641;22464251								
XRCC2	Frame_Shift_Del	32/280	p.F32Lfs*30	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										14678973;10517641;22464251								
ZFHX3	Frame_Shift_Ins	3434/3703	p.L3434Pfs*7	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27756245;31491374;26330387;29625055;30979864;30371878;26930642;23144151;26233892;17671116;24934715;27373158								
ZFHX3	Frame_Shift_Del	2241/3703	p.S2241Afs*14	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27756245;31491374;26330387;29625055;30979864;30371878;26930642;23144151;26233892;17671116;24934715;27373158								
ZFHX3	Nonsense_Mutation	24/3703	p.W24*	SAMPLE			True	False	Likely Loss-of-function	Likely Oncogenic										27756245;31491374;26330387;29625055;30979864;30371878;26930642;23144151;26233892;17671116;24934715;27373158								
